Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 317
Encontrada(s) 4 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Cryptococcal infection in HIV-infected patients with CD4 T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study

  • Pérez-Jacoiste Asín, María Asunción
  • Bisbal, Otilia
  • Iribarren, José Antonio
  • Pérez Rivilla, José Alfredo
  • Mican, Rafael
  • Dronda, Fernando
  • González Domenech, Carmen María
  • Vinuesa García, David
  • Macías, Juan
  • Lumbreras Bermejo, Carlos Juan
  • Moreno, Santiago
  • Rubio García, Rafael
Objectives: The World Health Organization recommends routinely screening HIV-infected patients with CD4+ T-cell counts <100/μL for cryptococcal infection to prevent cryptococcal meningitis (CM), based on studies in Sub-Saharan Africa where the prevalence of positive cryptococcal antigen (CrAg+) is ≥ 3% in this subgroup. Data about such prevalence in Spain are unavailable and rare in other European countries. Thus, the Spanish AIDS Study Group guidelines do not recommend routinely screening. We aim to determine the prevalence and outcomes of cryptococcal infection in this subgroup of patients in Spain. Methods: We determined CrAg using a lateral flow assay in banked plasma from participants in the cohort of the Spanish AIDS Research Network. Eligible patients had CD4+ T-cell counts ≤100/μL at the time of plasma collection and a follow-up >4 weeks, unless they died. Results: We included 576 patients from June 2004 to December 2017. Of these, 43 were CrAg+ for an overall prevalence of 7.5%. There were no differences depending on birthplace. The CrAg+ was independently associated with a higher mortality at eight weeks (hazard ratio (HR) 5.36, 95% confidence interval (CI) 1.46-19.56) and 6 months (HR 3.12, 95% CI 1.19-8.21). CM was reported in 10 of the 43 CrAg+ patients. There were no cases among negatives. Five patients had CM when the plasma was collected and five developed it during the follow-up. The number of subjects needed to screen to anticipate the diagnosis of one CM case was 114. Conclusions: The CrAg+ prevalence among HIV-infected patients with CD4+ T-cell counts ≤100/μL diagnosed in Spain, both immigrants and native-born Spanish, is >7%. Consequently, the Spanish AIDS Study Group guidelines have to be updated and recommend routine screening for cryptococcal infection in these patients. Future studies should explore whether this recommendation could be firmly applied to other European populations.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Altered thymocyte development observed in EphA4-deficient mice courses with changes in both thymic epithelial and extracellular matrix organization

  • García-Ceca Hernández, José Javier
  • Montero Herradón, Sara
  • González, Ana
  • Plaza, Rosa
  • Zapata González, Agustín Gregorio
Eph receptors and their ligands, Ephrins, are involved in the thymocyte-thymic epithelial cell (TEC) interactions, key for the functional maturation of both thymocytes and thymic epithelium. Several years ago, we reported that the lack of EphA4, a Eph of the subfamily A, coursed with reduced proportions of double positive (DP) thymocytes apparently due to an altered thymic epithelial stroma [Munoz et al. in J Immunol 177:804–813, 2006]. In the present study, we reevaluate the lymphoid, epithelial, and extracellular matrix (ECM) phenotype of EphA4−/− mice grouped into three categories with respect to their proportions of DP thymocytes. Our results demonstrate a profound hypocellularity, specific alterations of T cell differentiation that affected not only DP thymocytes, but also double negative and single positive T cell subsets, as well as the proportions of positively and negatively selected thymocytes. In correlation, thymic histological organization changed markedly, especially in the cortex, as well as the proportions of both Ly51+UEA-1− cortical TECs and Ly51−UEA-1+ medullary TECs. The alterations observed in the expression of ECM components (Fibronectin, Laminin, Collagen IV), integrin receptors (VLA-4, VLA-6), chemokines (CXCL12, CCL25, CCL21) and their receptors (CXCR4, CCR7, CCR9) and in vitro transwell assays on the capacity of migration of WT and mutant thymocytes suggest that the lack of EphA4 alters T-cell differentiation by presumably affecting cell adhesion between TECs and T-TEC interactions rather than by thymocyte migration.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Post-mortem findings in Spanish patients with COVID-19, a special focus on superinfections

  • Ruiz Cáceres, Inmaculada
  • Rubio García, Rafael
  • Rivero, Antonio
Introduction: Whole-body autopsies may be crucial to understand coronavirus disease 2019 (COVID-19) pathophysiology. We aimed to analyze pathological findings in a large series of full-body autopsies, with a special focus on superinfections. Methods: This was a prospective multicenter study that included 70 COVID-19 autopsies performed between April 2020 and February 2021. Epidemiological, clinical and pathological information was collected using a standardized case report form. Results: Median (IQR) age was 70 (range 63.75-74.25) years and 76% of cases were males. Most patients (90%,) had at least one comorbidity prior to COVID-19 diagnosis, with vascular risk factors being the most frequent. Infectious complications were developed by 65.71% of the patients during their follow-up. Mechanical ventilation was required in most patients (75.71%) and was mainly invasive. In multivariate analyses, length of hospital stay and invasive mechanical ventilation were significantly associated with infections (p = 0.036 and p = 0.013, respectively). Necropsy findings revealed diffuse alveolar damage in the lungs, left ventricular hypertrophy in the heart, liver steatosis and pre-infection arteriosclerosis in the heart and kidneys. Conclusion: Our study confirms the main necropsy histopathological findings attributed to COVID-19 in a large patient series, while underlining the importance of both comorbid conditions and superinfections in the pathology.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward

  • Ballestín, Raúl
  • Ferrer Pérez, Carmen
  • Reguilón, Marina D
  • Miñarro López, José
  • Rodríguez Arias, Marta
  • Giménez Gómez, Pablo
  • Gil De Biedma Elduayen, Leticia
  • Vidal Casado, Rebeca
  • O'Shea Gaya, María Esther
  • Colado Megías, María Isabel
The kynurenine (KYN) pathway of tryptophan (TRP) degradation is activated by stress and inflammatory factors. It is now well established that social stress induces the activation of the immune system, with central inflammation and KYN metabolism being two of the main factors linking stress with depression. The aim of the present study was to evaluate the long-lasting changes in the KYN pathway induced by social defeat (SD) associated with the resilience or susceptibility to an increase in the conditioned rewarding effects of cocaine. Mice were exposed to repeated SD and 3 weeks later, a conditioned place preference (CPP) induced by a subthreshold dose of cocaine (1.5 mg/kg) was developed. KYN levels in plasma, cerebellum, hippocampus, striatum and limbic forebrain were studied at the end of the CPP procedure. Changes in the KYN pathway after exposure to pharmacological (oxytocin and indomethacin) and environmental interventions (environmental enrichment) were also evaluated. Our results showed that defeated susceptible (SD-S) mice had higher conditioning scores than resilient mice (SD-R). In addition, although KYN concentration was elevated in all defeated mice, SD-R mice showed smaller increases in KYN concentration in the cerebellum than SD-S mice. Oxytocin or Indomethacin treatment before SD normalized cocaine-induced CPP, although the increase in the KYN pathway was maintained. However, environmental enrichment before SD normalized cocaine-induced CPP and prevented the increase in the KYN pathway. The present study highlights the role of the KYN pathway and anti-inflammatory drugs acting on TRP metabolism as pharmacological targets to potentiate resilience to social stress effects.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

  • Massanella, Marta|||0000-0002-3326-151X
  • Ouchi, Dan|||0000-0002-8630-152X
  • Marfil, Sílvia|||0000-0003-0139-5000
  • Llibre Codina, Josep Maria|||0000-0002-7158-6753
  • Puertas, Maria C.|||0000-0002-6750-2318
  • Buzón, Maria José|||0000-0003-4427-9413
  • Richman, Douglas D.
  • Orna, Elisa|||0000-0002-6862-9636
  • Stevenson, Mario
  • Gatell, José Mª|||0000-0002-4705-3244
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Negredo Puigmal, Eugènia|||0000-0001-5298-1734
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Blanco, Julià|||0000-0002-2225-0217
Background: HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to normal levels. Since intensification of cART with raltegravir reduced CD8 T-cell activation in the Discor-Ral and IntegRal studies, we have evaluated the effect of raltegravir intensification on several soluble inflammation markers in these studies. Methods: Longitudinal plasma samples (0-48 weeks) from the IntegRal (n=67, 22 control and 45 intensified individuals) and the Discor-Ral studies (44 individuals with CD4 T-cell counts,350 cells/μl, 14 control and 30 intensified) were assayed for 25 markers. Mann-Whitney, Wilcoxon, Spearman test and linear mixed models were used for analysis. Results: At baseline, different inflammatory markers were strongly associated with HCV co-infection, lower CD4 counts and with cART regimens (being higher in PI-treated individuals), but poorly correlated with detection of markers of residual viral replication. Although raltegravir intensification reduced inflammation in individuals with lower CD4 T-cell counts, no effect of intensification was observed on plasma markers of inflammation in a global analysis. An association was found, however, between reductions in immune activation and plasma levels of the coagulation marker D-dimer, which exclusively decreased in intensified patients on protease inhibitor (PI)-based cART regimens (P=0.040). Conclusions: The inflammatory profile in treated HIV-infected individuals showed a complex association with HCV co-infection, the levels of CD4 T cells and the cART regimen. Raltegravir intensification specifically reduced D-dimer levels in PI-treated patients, highlighting the link between cART composition and residual viral replication; however, raltegravir had little effect on other inflammatory markers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against hepatitis C virus genotype 1 or 4 in Caucasians

  • Real, Luis M.|||0000-0003-4932-7429
  • Neukam, Karin
  • Herrero del Rio, Mª del Rocío|||0000-0002-9678-0309
  • Guardiola, Josep M.
  • Reiberger, Thomas|||0000-0002-4590-3583
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • Salazar, Juliana|||0000-0002-3581-4499
  • Mandorfer, Mattias|||0000-0003-2330-0017
  • Merino, Dolores
  • Soriano, Vicente|||0000-0002-4624-5199
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • Macías, Juan|||0000-0002-4778-790X
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Caruz, Antonio
Objectives: The rs12979860 variant, linked to IL28B gene, predicts sustained viral response (SVR) to pegylated-interferon/ribavirin (pegIFN/RBV) therapy in Hepatitis C Virus genotype 1 or 4 (HCV-1/4)-infected patients. Recently, a functional variant, ss469415590, in linkage disequilibrium (LD) with rs12979860, has been discovered. Our objective was to assess the value of ss469415590 to predict SVR to pegIFN/RBV in Caucasian HCV-1/4-infected individuals and to compare its performance with that of rs12979860. Methods: 272 Caucasian HCV-1/4-infected patients who completed a course of pegIFN/RBV were genotyped for both rs12979860 and ss469415590 markers. Logistic regression models including factors with univariate association with SVR and each genetic marker were elaborated. The area under the receiver operating-characteristic curve (AUROC) was calculated for each model and both were compared. Results: Both markers were in LD (r = 0.82). For rs12979860, 66 (64.0%) CC versus 56 (33.1%) T allele carriers achieved SVR (Adjusted OR = 4.156, 95%CI = 2.388-7.232, p = 4.647×10). For ss469415590, 66 (66.0%) TT/TT versus 56 (32.5%) -G allele carriers (Adjusted OR = 4.783, 95% CI = 2.714-8.428, p = 6.153×10) achieved SVR. The AUROC of the model including rs12979860 was 0.742 (95%CI = 0.672-0.813) and of that based on ss469415590 was 0.756 (95%CI = 0.687-0.826) (p = 0.780). Conclusions: The ss469415590 variant shows an equivalent performance to predict SVR to pegIFN/RBV than the rs2979860 in Caucasian HCV-1/4-infected patients. © 2014 Real et al.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

HEBE, A novel chimeric chronokine for ameliorating memory deficits in Alzheimer's disease

  • Esandi Jauregui, Jon|||0000-0001-5529-2686
  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Capilla López, Maria Dolores|||0000-0002-9483-4887
  • Blanch Garcia, Rebeca|||0000-0001-6726-4084
  • Edo Salvador, Ángel
  • Ramirez-Gómez, David
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Almolda Ardid, Beatriz|||0000-0001-6631-4385
  • Saura, Carlos Alberto
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by amyloid-β and Tau protein depositions, with treatments focusing on single proteins have shown limited success due to the complexity of pathways involved. This study explored the potential of chronokines -proteins that modulate aging-related processes- as an alternative therapeutic approach. Specifically, we focused on a novel pleiotropic chimeric protein named HEBE, combining s-KL, sTREM2 and TIMP2, guided by bioinformatic analyses to ensure the preservation of each protein's conformation, crucial for their functions. In vitro studies confirmed HEBE's stability and enzymatic activities, even suggesting it has different activities compared to the individual chronokines. In vivo experiments on APP/Tau mice revealed improved learning and memory functions with HEBE treatment, along with decreased levels of phosphorylated Tau and minor effects on amyloid-β levels. These findings suggest that HEBE is as a promising therapeutic candidate for ameliorating memory deficits and reducing pTau in an AD mouse model.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Efficacy of Tocilizumab for hospitalized patients with COVID-19 pneumonia and high IL-6 levels: A randomized controlled trial

  • Sellarès-Nadal, Júlia|||0000-0002-0209-6494
  • Espinosa-Pereiro, Juan|||0000-0002-7238-8337
  • Burgos, Joaquín|||0000-0001-8445-3047
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Guillén-Del-Castillo, Alfredo|||0000-0003-0626-507X
  • Augustin Recio, Salvador|||0000-0002-3515-9033
  • Bañares-Sánchez, Joan
  • Prio-Ruatg, Alba
  • Martínez-Valle, Ferran
  • Kirkegaard, Cristina|||0000-0001-9035-1450
  • Sánchez Montalvá, Adrián|||0000-0002-2194-5447
Background: The objective of this clinical trial is to evaluate the efficacy and safety of IL-6 driven personalized treatment strategy with tocilizumab in patients with severe COVID-19 pneumonia. Trial design: Randomized, controlled, open-label, single-center trial of a tocilizumab treatment strategy in adult patients hospitalized with severe COVID-19 pneumonia and IL-6 serum levels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission, a randomised placebo-controlled clinical trial of GETECCU

  • P. Gisbert, Javier|||0000-0003-2090-3445
  • Donday, María G.
  • Riestra, Sabino|||0000-0002-9383-3698
  • Lucendo, Alfredo J.|||0000-0003-1183-1072
  • Benítez, José Manuel|||0000-0001-8898-3141
  • Navarro-Llavat, Mercè|||0000-0002-1132-0427
  • Barrio, Jesús|||0000-0001-7087-3921
  • Morales-Alvarado, Víctor J.
  • Rivero, Montserrat|||0000-0002-5834-1559
  • Busquets, David|||0000-0002-9385-1415
  • Leo Carnerero, Eduardo|||0000-0002-1267-5211
  • Merino, Olga|||0000-0002-1362-4475
  • Nantes Castillejo, Óscar|||0000-0002-3587-1039
  • Navarro, Pablo|||0000-0001-6228-3462
  • Van Domselaar, Manuel|||0000-0002-9950-2216
  • Gutiérrez Casbas, Ana|||0000-0002-5460-4139
  • Alonso-Abreu, Inmaculada|||0000-0003-0406-029X
  • Mejuto, Rafael
  • Fernández-Salazar, Luis|||0000-0002-9951-7979
  • Iborra, Marisa|||0000-0001-7360-7581
  • Martín-Arranz, María Dolores|||0000-0002-1872-0917
  • Pineda, Juan Ramón
  • Sampedro, Manuela Josefa
  • Serra Nilsson, Katja
  • Bouhmidi, Abdel
  • Batista, Lissette
  • Muñoz-Villafranca, Carmen|||0000-0002-8060-8889
  • Rodríguez-Lago, Iago|||0000-0003-1133-4578
  • Ceballos, Daniel
  • Guerra, Iván|||0000-0002-5175-2515
  • Mañosa i Ciria, Míriam|||0000-0002-9051-2581
  • Marín Jiménez, Ignacio|||0000-0001-5424-2484
  • Torrella, Emilio
  • Vera Mendoza, Maribel
  • Casanova, María José|||0000-0001-8233-9638
  • de Francisco, Ruth|||0000-0001-8476-1672
  • Arias-González, Laura|||0000-0003-2132-9350
  • Marín Pedrosa, Sandra
  • García-Bosch, Orlando
  • García Alonso, Francisco Javier
  • Delgado-Guillena, Pedro|||0000-0002-5798-5491
  • García García, María José|||0000-0002-6517-7005
  • Torrealba, Leyanira|||0000-0002-3144-3408
  • Núñez Ortiz, Andrea
  • Vicuña Arregui, Miren
  • Bosca-Watts, Marta Maia|||0000-0001-7495-8797
  • Blázquez, Isabel|||0000-0003-2429-8174
  • Acosta, Diana|||0000-0001-8347-6642
  • Garre, Ana
  • Baldán, Montse|||0000-0003-0848-8154
  • Martínez, Concepción
  • Barreiro de-Acosta, Manuel|||0000-0001-5915-1477
  • Domènech, Eugeni|||0000-0002-2315-7196
  • Esteve, Maria|||0000-0001-7716-0027
  • García-Sánchez, Valle
  • Nos, Pilar|||0000-0002-6619-1511
  • Panés, Julián|||0000-0002-4971-6902
  • Chaparro, María|||0000-0002-9275-4242
  • Ramírez, Esther
  • Alvarez-Manceñido, Felipe
  • Sánchez-Casanueva, Tomás
  • Cárdenas Aranzana, Manuel J.
  • Gracia García, Berta
  • Caro-Patón, Tomás
  • Seguí Solanes, Carlos
  • Giménez Poderós, Teresa|||0000-0002-7611-7358
  • Castelló Nòria, Àngela
  • Villalba Moreno, Angela|||0000-0002-8658-120X
  • Bustinza Txertudi, Alazne
  • Aranda Alcántara, María
  • Guillot Yacyszyn, Verónica
  • Morales Martínez, Lorena
  • Gracia, Ángel
  • Virgós Aller, Tirso
  • Espino Paisán, Esther
  • Hernando Verdugo, Mercedes
  • Tordera, María
  • Cárdenas, Cristina
  • Sánchez Ulayar, Azhara
  • Ferrer-Artola, Anna|||0000-0003-0424-7353
  • Ventura López, Purificación
  • Loizaga Diaz, Irunne
  • Santos, Amaya
  • Amat López, Mireya
  • Hernández Musiesa, Belén
  • Quiñones Ribas, Carles|||0000-0003-2974-2086
  • Mur Mur, Ana
  • García Motos, Consuelo
  • Sánchez Guerrero, Amelia
Background and objectives: Primary objectives: to compare the rates of sustained clinical remission at 12 months in patients treated with antitumour necrosis factor (anti-TNF) and immunomodulators who withdraw anti-TNF treatment versus those who maintain it. Secondary objectives: to evaluate the effect of anti-TNF withdrawal on relapse-free time, endoscopic and radiological activity, safety, quality of life and work productivity; and to identify predictive factors for relapse. Design: Prospective, quadruple-blind, multicentre, randomised, controlled trial. Patients with ulcerative colitis or Crohn's disease in clinical remission for.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas

  • Justicia-Lirio, Pedro
  • Tristán-Manzano, María|||0000-0001-8721-1414
  • Maldonado-Pérez, Noelia|||0000-0001-5975-0488
  • Barbero-Jiménez, Carmen
  • Cortijo-Gutiérrez, Marina|||0000-0002-0161-515X
  • Pavlovic, Kristina
  • Molina-Estevez, Francisco J.
  • Muñoz, Pilar
  • Hinckley-Boned, Ana
  • Rodriguez-Madoz, Juan Roberto|||0000-0003-4327-1866
  • Prosper, Felipe|||0000-0001-6115-8790
  • Griñán-Lison, Carmen
  • Navarro-Marchal, Saúl Abenhamar|||0000-0003-3508-6396
  • Panisello, Carla|||0000-0002-8437-4418
  • Muñoz-Ballester, Julia
  • González-Sierra, Pedro A.
  • Herrera, Concha
  • Marchal, Juan A.
  • Martín, Francisco|||0000-0003-1961-8612
Although chimeric antigen receptor (CAR) T cell therapy has revolutionized type B cancer treatment, efficacy remains limited in various lymphomas and solid tumors. Reinforcing conventional CAR-T cells to release cytokines can improve their efficacy but also increase safety concerns. Several strategies have been developed to regulate their secretion using minimal promoters that are controlled by chimeric proteins harboring transactivators. However, these chimeric proteins can disrupt the normal physiology of T cells. Here, we present the first transactivator-free anti-CD19 CAR-T cells able to control IL-18 expression (iTRUCK19.18) under ultra-low doses of doxycycline and without altering cellular fitness. Interestingly, IL-18 secretion requires T cell activation in addition to doxycycline, allowing the external regulation of CAR-T cell potency. This effect was translated into an increased CAR-T cell antitumor activity against aggressive hematologic and solid tumor models. In a clinically relevant context, we generated patient-derived iTRUCK19.18 cells capable of eradicating primary B cells tumors in a doxycycline-dependent manner. Furthermore, IL-18-releasing CAR-T cells polarized pro-tumoral macrophages toward an antitumoral phenotype, suggesting potential for modulating the tumor microenvironment. In summary, we showed that our platform can generate exogenously controlled CAR-T cells with enhanced potency and in the absence of transactivators.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV?

  • Fuster, Daniel|||0000-0003-1262-5860
  • So-Armah, Kaku|||0000-0003-1505-6384
  • Cheng, Debbie M.
  • Blokhina, Elena
  • Patts, Gregory
  • Lioznov, Dmitry|||0000-0003-3643-7354
  • Gnatienko, Natalia
  • Long, Michelle T.
  • Freiberg, Matthew S.|||0000-0002-3699-4022
  • Tindle, Hilary|||0000-0002-7581-7483
  • Samet, Jeffrey H.|||0000-0002-0897-3400
Background: Cigarette smoking has been associated with liver fibrosis in the setting of hepatitis C virus (HCV) infection but has not been studied among people with HIV (PWH) who consume alcohol. Methods: This is a cross-sectional study of PWH with heavy drinking and daily smoking in St. Petersburg, Russia. The primary independent variable was past 30-day cigarettes per day (cpd), and the secondary independent variable was pack-years at study entry. Advanced liver fibrosis was defined as FIB-4 > 3.25. Analyses were adjusted for gender, body mass index (BMI), past 30-day number of heavy drinking days, HCV and CD4 count. Results: Participants (n = 400) were two-thirds male (67.3%), young (median age 38 years), lean (median BMI 22), HCV antibody positive (84.5%) and not severely immune suppressed (median CD4 count 351). The median number of past-month cpd was 20 (IQR: 15-25), and the median pack-years was 24 (IQR: 17-31.8). The prevalence of advanced liver fibrosis was 11.3% (45/400). In the adjusted logistic regression analyses, we did not observe a significant association between cpd [middle (10.1-20 cigarettes) vs. lowest (5-10 cigarettes) category (adjusted odds ratio [aOR] (95% confidence interval [CI]): 1.06 (0.40-2.83), highest (>20.0 cigarettes) vs. lowest category aOR (95% CI): 0.65 (0.21-1.99), global p -value = 0.62]. The secondary analysis with pack-years yielded similar results [middle (20.1-30 pack-years) vs. lowest category (≤20 pack-years) aOR (95% CI): 0.81 (0.33-1.99), highest category (>30 pack-years) vs. lowest category aOR (95% CI): 0.91 (0.38-2.19); global p -value = 0.58]. Conclusions: In this Russian cohort of PWH, we did not detect an association between recent cigarette use or mean pack-years and advanced liver fibrosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder, Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study

  • Torres-Galván, Sandra
  • Flores-López, María|||0000-0003-3489-1465
  • Ochoa, Enrique
  • Requena-Ocaña, Nerea|||0000-0003-3257-8459
  • Araos, Pedro|||0000-0001-5172-8796
  • Herrera-Imbroda, Jesús
  • Muga, Roberto|||0000-0001-6301-431X
  • Serrano, Antonia
  • Rodríguez de Fonseca, Fernando|||0000-0002-4516-5795
  • Pavón-Morón, Francisco Javier|||0000-0002-5256-8904
  • Haro, Gonzalo
  • García Marchena, Nuria|||0000-0002-0575-3613
Dual diagnosis in individuals with cocaine use disorders (CUDs) presents a mental health challenge marked by an increased susceptibility to disabling morbidities and premature mortality. Despite extensive research on depression and anxiety, other prevalent comorbidities, such as psychotic and personality disorders, have received less attention. This study explores inflammation-related mediators as potential biomarkers for CUD and dual diagnosis with schizophrenia (SCZ) or antisocial personality disorder (APD). This exploratory study included 95 participants, comprising 40 healthy subjects and 55 abstinent patients with CUD. Lifetime CUD was diagnosed either as single diagnosis (CUD group, N = 25) or as a dual diagnosis (DD group. N = 30) with SCZ (CUD+SCZ subgroup) or APD (CUD+APD subgroup). Participants were clinically assessed, and the plasma concentrations of growth factors (i.e., G-CSF, BDNF, and VEGF-A) and chemokines (i.e., CCL11/eotaxin-1, CCL2/MCP-1, and CXCL12/SDF-1) were determined and log(10)-transformed for analysis. Growth factors and chemokines were dysregulated by CUD and psychiatric diagnoses. Specifically, patients in the CUD group exhibited significantly lower concentrations of G-CSF and CCL11/eotaxin-1 than the control group. In contrast, the DD group showed significantly higher concentrations of all analytes than both the CUD and control groups. Additionally, no differences in these analytes were observed between the CUD+SCZ and CUD+APD subgroups within the DD group. Regarding cocaine-related variables, significant associations were identified in the CUD group: an inverse correlation between the age at first cocaine use and the concentrations of BDNF and CCL2/MCP-1; and a positive correlation between the duration of the cocaine abstinence and the concentrations of BDNF and CCL11/eotaxin-1. Lastly, a logistic regression model incorporating all these analytes demonstrated high discriminatory power in distinguishing patients with CUD alone from those with dual diagnosis. Individuals with dual diagnosis of CUD exhibit elevated concentrations of growth factors and chemokines, distinguishing them from those with CUD alone. It is unclear whether the differences in these inflammatory mediators are specific to the presence of SCZ and APD. The study highlights potential biomarkers and associations, providing valuable insights into the intricate interplay of CUD and psychiatric disorders to enhance clinical diagnosis and therapeutics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population, a cross-sectional study

  • Torres-Méndez, Jeimy Katherine|||0000-0001-6299-8222
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Vendrell Tito, Pau|||0009-0003-2020-5126
  • Ortega, Emilio|||0000-0002-2217-8905
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Muscarà, Andrea
  • Rubinat, Esther|||0000-0003-0232-9777
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Hernández García, Marta|||0000-0003-1237-298X
  • Rossell, Joana|||0000-0003-1500-6379
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
  • Julve i Gil, Josep|||0000-0002-6531-2246
Background: Accumulating evidence suggests that niacin interventions may have a beneficial role in preventing ophthalmological microangiopathic remodeling. This study aimed to assess the impact of niacin intake on the presence of diabetic retinopathy (DR) in two independent Mediterranean cohorts of individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods: Cross-sectional, population-based epidemiologic study. A total of 243 individuals with T1D, and 291 individuals with T2D. All participants underwent an eye examination. Dietary niacin intake was analyzed using a validated Spanish 101-items food frequency questionnaire consumption. The association between niacin intake and DR was assessed using a multivariate logistic regression, with potential non-linear associations further explored through restricted cubic spline regression. DR diagnostic was established via multifield stereoscopic retinal photography, in accordance with the international consensus on DR. Results: DR was identified in 103 out of 243 individuals with T1D and 144 out of 291 with T2D. Dietary niacin intake did not differ within the study groups according to DR status. Multivariate logistic regression models also revealed no association between dietary niacin intake and DR. As previously described, the duration of diabetes for T1D and T2D, [OR (95%CI), 1.02 (1.01-1.03), and 1.02 (1.02-1.03), respectively] and glycated hemoglobin (HbA1c) [OR (95%CI), 1.16 (1.09-1.24), and 1.14 (1.09-1.18), respectively] were identified as the main determinant variables for DR in both groups. Conclusions: We found that dietary niacin intake was not associated with the presence of RD in subjects with either T1D or T2D. Further research is needed to better understand the potential role of niacin in the development or prevention of DR.
Repisalud
Publicación Artículo científico (JournalArticle)

Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication

  • Coiras, Mayte
  • Montes, Marta
  • Montanuy, Immaculada
  • Lopez-Huertas, Maria Rosa
  • Mateos, Elena
  • Le Sommer, Caroline
  • Garcia-Blanco, Mariano A
  • Hernández-Munain, Cristina
  • Alcamí, José
  • Suñé, Carlos
BACKGROUND: Control of RNA polymerase II (RNAPII) release from pausing has been proposed as a checkpoint mechanism to ensure optimal RNAPII activity, especially in large, highly regulated genes. HIV-1 gene expression is highly regulated at the level of elongation, which includes transcriptional pausing that is mediated by both viral and cellular factors. Here, we present evidence for a specific role of the elongation-related factor TCERG1 in regulating the extent of HIV-1 elongation and viral replication in vivo. RESULTS: We show that TCERG1 depletion diminishes the basal and viral Tat-activated transcription from the HIV-1 LTR. In support of a role for an elongation mechanism in the transcriptional control of HIV-1, we found that TCERG1 modifies the levels of pre-mRNAs generated at distal regions of HIV-1. Most importantly, TCERG1 directly affects the elongation rate of RNAPII transcription in vivo. Furthermore, our data demonstrate that TCERG1 regulates HIV-1 transcription by increasing the rate of RNAPII elongation through the phosphorylation of serine 2 within the carboxyl-terminal domain (CTD) of RNAPII and suggest a mechanism for the involvement of TCERG1 in relieving pausing. Finally, we show that TCERG1 is required for HIV-1 replication. CONCLUSIONS: Our study reveals that TCERG1 regulates HIV-1 transcriptional elongation by increasing the elongation rate of RNAPII and phosphorylation of Ser 2 within the CTD. Based on our data, we propose a general mechanism for TCERG1 acting on genes that are regulated at the level of elongation by increasing the rate of RNAPII transcription through the phosphorylation of Ser2. In the case of HIV-1, our evidence provides the basis for further investigation of TCERG1 as a potential therapeutic target for the inhibition of HIV-1 replication.
Repisalud
Publicación Artículo científico (JournalArticle)

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

  • Sordo, Luis
  • Barrio, Gregorio
  • Bravo, Maria Jose
  • Indave-Ruiz, Blanca Iciar
  • Degenhardt, Louisa
  • Wiessing, Lucas
  • Ferri, Marica
  • Pastor-Barriuso, Roberto
Objective To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and cessation of treatment.Design Systematic review and meta-analysis.Data sources Medline, Embase, PsycINFO, and LILACS to September 2016.Study selection Prospective or retrospective cohort studies in people with opioid dependence that reported deaths from all causes or overdose during follow-up periods in and out of opioid substitution treatment with methadone or buprenorphine.Data extraction and synthesis Two independent reviewers performed data extraction and assessed study quality. Mortality rates in and out of treatment were jointly combined across methadone or buprenorphine cohorts by using multivariate random effects meta-analysis.Results There were 19 eligible cohorts, following 122 885 people treated with methadone over 1.3-13.9 years and 15 831 people treated with buprenorphine over 1.1-4.5 years. Pooled all cause mortality rates were 11.3 and 36.1 per 1000 person years in and out of methadone treatment (unadjusted out-to-in rate ratio 3.20, 95% confidence interval 2.65 to 3.86) and reduced to 4.3 and 9.5 in and out of buprenorphine treatment (2.20, 1.34 to 3.61). In pooled trend analysis, all cause mortality dropped sharply over the first four weeks of methadone treatment and decreased gradually two weeks after leaving treatment. All cause mortality remained stable during induction and remaining time on buprenorphine treatment. Overdose mortality evolved similarly, with pooled overdose mortality rates of 2.6 and 12.7 per 1000 person years in and out of methadone treatment (unadjusted out-to-in rate ratio 4.80, 2.90 to 7.96) and 1.4 and 4.6 in and out of buprenorphine treatment.Conclusions Retention in methadone and buprenorphine treatment is associated with substantial reductions in the risk for all cause and overdose mortality in people dependent on opioids. The induction phase onto methadone treatment and the time immediately after leaving treatment with both drugs are periods of particularly increased mortality risk, which should be dealt with by both public health and clinical strategies to mitigate such risk. These findings are potentially important, but further research must be conducted to properly account for potential confounding and selection bias in comparisons of mortality risk between opioid substitution treatments, as well as throughout periods in and out of each treatment.
Repisalud
Publicación Artículo científico (JournalArticle)

Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers

  • Casado, Concepcion
  • Marrero-Hernández, Sara
  • Márquez-Arce, Daniel
  • Pernas, Maria
  • Marfil, Silvia
  • Borràs-Grañana, Ferran
  • Olivares, Isabel
  • Cabrera-Rodríguez, Romina
  • Valera, María-Soledad
  • de Armas-Rillo, Laura
  • Lemey, Philippe
  • Blanco, Julià
  • Valenzuela-Fernández, Agustín
  • Lopez-Galindez, Luis Cecilio
A small group of HIV-1-infected individuals, called long-term nonprogressors (LTNPs), and in particular a subgroup of LTNPs, elite controllers (LTNP-ECs), display permanent control of viral replication and lack of clinical progression. This control is the result of a complex interaction of host, immune, and viral factors. We identified, by phylogenetic analysis, a cluster of LTNP-ECs infected with very similar low-replication HIV-1 viruses, suggesting the contribution of common viral features to the clinical LTNP-EC phenotype. HIV-1 envelope (Env) glycoprotein mediates signaling and promotes HIV-1 fusion, entry, and infection, being a key factor of viral fitness in vitro, cytopathicity, and infection progression in vivo Therefore, we isolated full-length env genes from viruses of these patients and from chronically infected control individuals. Functional characterization of the initial events of the viral infection showed that Envs from the LTNP-ECs were ineffective in the binding to CD4 and in the key triggering of actin/tubulin-cytoskeleton modifications compared to Envs from chronic patients. The viral properties of the cluster viruses result in a defective viral fusion, entry, and infection, and these properties were inherited by every virus of the cluster. Therefore, inefficient HIV-1 Env functions and signaling defects may contribute to the low viral replication capacity and transmissibility of the cluster viruses, suggesting a direct role in the LTNP-EC phenotype of these individuals. These results highlight the important role of viral characteristics in the LTNP-EC clinical phenotype. These Env viral properties were common to all the cluster viruses and thus support the heritability of the viral characteristics.IMPORTANCE HIV-1 long-term nonprogressor elite controller patients, due to their permanent control of viral replication, have been the object of numerous studies to identify the factors responsible for this clinical phenotype. In this work, we analyzed the viral characteristics of the envelopes of viruses from a phylogenetic cluster of LTNP-EC patients. These envelopes showed ineffective binding to CD4 and the subsequent signaling activity to modify actin/tubulin cytoskeletons, which result in low fusion and deficient entry and infection capacities. These Env viral characteristics could explain the nonprogressor clinical phenotype of these patients. In addition, these inefficient env viral properties were present in all viruses of the cluster, supporting the heritability of the viral phenotype.
Repisalud
Publicación Artículo científico (JournalArticle)

Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis

  • Garcia-Alvarez, Monica
  • Jimenez-Sousa, Maria Angeles
  • Fernandez-Rodriguez, Amanda
  • Guzman-Fulgencio, Maria
  • Resino, Salvador
There is growing evidence that vitamin D is related to chronic hepatitis C (CHC) pathogenicity. We analyzed the relationship of vitamin D status with advanced liver fibrosis (ALF) in CHC treatment-naïve patients and sustained virologic response (SVR) in CHC patients on pegylated interferon alpha plus ribavirin (pegIFNα/ribavirin) therapy. We performed a meta-analysis of all eligible studies published to date (April, 2014) in PubMed, SCOPUS, LILACS, and the Cochrane Library, assessing plasma/serum vitamin D levels related to ALF and/or SVR. Pooled odds ratios (ORs) were estimated by either fixed or random effects models. Fourteen studies were selected from the literature search, seven for ALF (1,083 patients) and 11 for SVR (2,672 patients). For liver fibrosis, low vitamin D status was related to a diagnosis of ALF, with the cutoffs of 10 ng/mL (OR=2.37, 95% confidence interval [CI]=1.20, 4.72) and 30 ng/mL (OR=2.22, 95% CI=1.24, 3.97) being significant, and a near-significance for 20 ng/mL (OR=1.44, 95% CI=0.99, 2.12). Regarding SVR, a significant heterogeneity among studies was found (P<0.001), and we only found a significant association with SVR for a vitamin D cutoff of 20 ng/mL (OR=0.53, 95% CI=0.31, 0.91). When meta-analysis was performed excluding the outliers, significant pooled ORs were found for all patients (10 ng/mL [OR=0.48, 95% CI=0.34, 0.67] and 20 ng/mL [OR=0.58, 95% CI=0.45, 0.76]) and GT1/4 patients (10 ng/mL [OR=0.53, 95% CI=0.34, 0.81] and 20 ng/mL [OR=0.54, 95% CI=0.39, 0.74]). Conclusion: Low vitamin D status in CHC patients is associated with a higher likelihood of having ALF and lower odds of achieving SVR following pegIFNα/ribavirin therapy.
Repisalud
Publicación Artículo científico (JournalArticle)

High-Risk Sexual Practices Contribute to HIV-1 Double Infection Among Men Who Have Sex with Men in Madrid.

  • Casado, Concepcion
  • Pernas, Maria
  • Rava, Marta
  • Ayerdi, Oskar
  • Vera, Mar
  • Alenda, Raquel
  • Jimenez Sancho, Maria Pilar
  • Docando, Felix
  • Olivares, Isabel
  • Zaballos, Ángel
  • Vicario, José Luis
  • Rodríguez, Carmen
  • Del Romero, Jorge
  • Lopez-Galindez, Luis Cecilio
Data on the prevalence of double infection (DI) in HIV individuals are lacking in Spain. To fill this gap, we analyzed the prevalence of DI in a cohort of men who have sex with men (MSM) and examined factors contributing to DI. We selected 81 MSM attending Centro Sanitario Sandoval, a sexually transmitted diseases clinic in Madrid. We obtained by ultra-deep sequencing the proviral sequences in gag and env genes and performed a phylogenetic analysis for the identification of DI. Clinical, behavioral, host, and viral factors were studied for its association with DI. We detected six individuals with DI and one case of superinfection with a global prevalence of 8.6%. The genetic distance among the subtype B viruses in monoinfected individuals (24.4%) was lower than the distance between the two viruses in subtype B DI individuals (29.5%). Individuals with a high number of sexual contacts (>25 partners/year) had an 8.66 times higher risk of DI (p = .017). In this MSM cohort the prevalence of HIV DI was estimated at 8.6%. DI was strongly associated with the number of sexual partners. Because of the pathogenic consequences of HIV DI, this high prevalence should promote public health programs targeted at high-risk population such as MSM for the control of HIV infection and DI. HIV DI should be considered for a better clinical management of these individuals.
Repisalud
Publicación Artículo científico (JournalArticle)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

  • Vigon-Hernandez, Lorena
  • Vázquez-Morón, Sonia
  • Berenguer, Juan
  • González-García, Juan
  • Jimenez-Sousa, Maria Angeles
  • Guardiola, Josep M
  • Crespo, Manuel
  • de Los Santos, Ignacio
  • Von Wichmann, Miguel A
  • Carrero, Ana
  • Yélamos, María Belén
  • Gómez, Julián
  • Resino, Salvador
  • Martinez, Isidoro
  • GESIDA 3603b Cohort Study Group
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. Plasma samples at baseline and week 24 after SVR were used to perform neutralization assays against five JFH1-based HCV recombinant viruses coding for E1 and E2 from genotypes 1a (H77), 1b (J4), 2a (JFH1), 3a (S52) and 4a (ED43). At baseline, the majority of plasma samples neutralized 1a, 1b, 2a, and 4a, but not 3a, genotypes. Twenty-four weeks following SVR, most neutralizing titers declined substantially. Furthermore, titers against 3a and 2a were not detected in many patients. Plasma samples with high HCV-nAb titers neutralized all genotypes, and the highest titers at the starting point correlated with the highest titers at week 24 after SVR. In conclusion, high titers of broad-spectrum HCV-nAbs were detected in HIV/HCV-coinfected individuals, however, those titers declined soon after SVR.
Repisalud
Publicación Artículo científico (JournalArticle)

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.

  • Monge Corella, Susana
  • Guillot, Vicente
  • Alvarez, Marta
  • Chueca, Natalia
  • Stella, Natalia
  • Peña, Alejandro
  • Delgado, Rafael
  • Córdoba, Juan
  • Aguilera, Antonio
  • Vidal, Carmen
  • García, Federico
The aim was to analyse trends in clinically relevant resistance to first-line antiretroviral drugs in Spain, applying the Stanford algorithm, and to compare these results with reported Transmitted Drug Resistance (TDR) defined by the 2009 update of the WHO SDRM list. We analysed 2781 sequences from ARV naive patients of the CoRIS cohort (Spain) between 2007-2011. Using the Stanford algorithm "Low-level resistance", "Intermediate resistance" and "High-level resistance" categories were considered as "Resistant". 70% of the TDR found using the WHO list were relevant for first-line treatment according to the Stanford algorithm. A total of 188 patients showed clinically relevant resistance to first-line ARVs [6.8% (95%Confidence Interval: 5.8-7.7)], and 221 harbored TDR using the WHO list [7.9% (6.9-9.0)]. Differences were due to a lower prevalence in clinically relevant resistance for NRTIs [2.3% (1.8-2.9) vs. 3.6% (2.9-4.3) by the WHO list] and PIs [0.8% (0.4-1.1) vs. 1.7% (1.2-2.2)], while it was higher for NNRTIs [4.6% (3.8-5.3) vs. 3.7% (3.0-4.7)]. While TDR remained stable throughout the study period, clinically relevant resistance to first line drugs showed a significant trend to a decline (p = 0.02). Prevalence of clinically relevant resistance to first line ARVs in Spain is decreasing, and lower than the one expected looking at TDR using the WHO list. Resistance to first-line PIs falls below 1%, so the recommendation of screening for TDR in the protease gene should be questioned in our setting. Cost-effectiveness studies need to be carried out to inform evidence-based recommendations.
Repisalud
Publicación Artículo científico (JournalArticle)

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors

  • Alejos, Belén
  • Suárez-García, Inés
  • Bisbal, Otilia
  • Iribarren, José Antonio
  • Asensi, Víctor
  • Górgolas, Miguel
  • Muga, Roberto
  • Moreno, Santiago
  • Jarrin Vera, Inmaculada
  • CoRIS Cohort
Background: We aimed to describe the most frequently prescribed initial antiretroviral therapy (ART) regimens in recent years in HIV-positive persons in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) and to investigate factors associated with the choice of each regimen. Methods: We analyzed initial ART regimens prescribed in adults participating in CoRIS from 2014 to 2017. Only regimens prescribed in >5% of patients were considered. We used multivariable multinomial regression to estimate Relative Risk Ratios (RRRs) for the association between sociodemographic and clinical characteristics and the choice of the initial regimen. Results Among 2874 participants, abacavir(ABC)/lamivudine(3TC)/dolutegavir(DTG) was the most frequently prescribed regimen (32.1%), followed by tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)/elvitegravir(EVG)/cobicistat(COBI) (14.9%), TDF/FTC/rilpivirine (RPV) (14.0%), tenofovir alafenamide (TAF)/FTC/EVG/COBI (13.7%), TDF/FTC+DTG (10.0%), TDF/FTC+darunavir/ritonavir or darunavir/cobicistat (bDRV) (9.8%) and TDF/FTC+raltegravir (RAL) (5.6%). Compared with ABC/3TC/DTG, starting TDF/FTC/RPV was less likely in patients with CD4<200 cells/mu L and HIV-RNA> 100.000 copies/mL. TDF/FTC+DTG was more frequent in those with CD4< 200 cells/mu L and HIV-RNA>100.000 copies/mL. TDF/FTC+FTC+bDRV were also more frequent among patients with CD4< 200 cells//mu L and with transmission categories other than men who have sex with men. Compared with ABC/3TC/DTG, the prescription of other initial ART regimens decreased from 2014-2015 to 2016-2017 with the exception of TDF/FTC+DTG. Differences in the choice of the initial ART regimen were observed by hospitals' location. Conclusions: The choice of initial ART regimens is consistent with Spanish guidelines' recommendations, but is also clearly influenced by physician's perception based on patient's clinical and sociodemographic variables and by the prescribing hospital location.
Repisalud
Publicación Artículo científico (JournalArticle)

High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control

  • Gutiirrez-Rivas, Monica
  • Jimenez-Sousa, Maria Angeles
  • Rallón, Norma
  • Jiménez, José Luis
  • Restrepo, Clara
  • León, Agathe
  • Montero-Alonso, Marta
  • González-García, Juan
  • Muñoz-Fernández, María Ángeles
  • Benito, José Miguel
  • Resino, Salvador
Our aim was to analyze the relationship between plasma inflammatory biomarkers and CD4+ T-cells evolution in human immunodeficiency virus (HIV) elite controllers (HIV-ECs) with a suppressed viremia. We carried out a retrospective study in 30 HIV-ECs classified into two groups: those showing no significant loss of CD4+ T-cells during the observation period (stable CD4+, n = 19) and those showing a significant decrease of CD4+ T-cells (decline CD4+, n = 11). Baseline plasma biomarkers were measured using a multiplex immunoassay: sTNF-R1, TRAIL, sFas (APO), sFasL, TNF-α, TNF-β, IL-8, IL-18, IL-6, IL-10, IP-10, MCP-1, MIP-1α, MIP-1β, RANTES, SDF1α, GRO-α, and CCL11. Baseline levels of sTNF-R1 and CCL11 and sTNF-R1/TNF-α ratio correlated with the slope of CD4+ T-cells (cells/μl/year) during follow-up [r = -0.370 (p = 0.043), r = -0.314 (p = 0.091), and r = -0.381 (p = 0.038); respectively]. HIV-ECs with declining CD4+ T-cells had higher baseline plasma levels of sTNF-R1 [1,500.7 (555.7; 2,060.7) pg/ml vs. 450.8 (227.9; 1,263.9) pg/ml; p = 0.018] and CCL11 [29.8 (23.5; 54.9) vs. 19.2 (17.8; 29.9) pg/ml; p = 0.041], and sTNF-R1/TNF-α ratio [84.7 (33.2; 124.2) vs. 25.9 (16.3; 75.1); p = 0.012] than HIV-1 ECs with stable CD4+ T-cells. The area under the receiver operating characteristic (ROC) curve [area under ROC curve (AUROC)] were 0.758 ± 0.093 (sTNF-R1), 0.727 ± 0.096 (CCL11), and 0.777 ± 0.087 (sTNF-R1/TNF-α). The cut-off of 75th percentile (high values) for these biomarkers had 71.4% positive predictive value and 73.9% negative predictive value for anticipating the evolution of CD4+ T-cells. In conclusion, the loss of CD4+ T-cells in HIV-ECs was associated with higher levels of two plasma inflammatory biomarkers (sTNF-R1 and CCL11), which were also reasonably accurate for the prediction of the CD4+ T-cells loss.
Repisalud
Publicación Artículo científico (JournalArticle)

Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.

  • Hernando Sebastian, Victoria
  • Cuevas, Maria Teresa
  • Perez-Olmeda, Mayte
  • Tasias, Maria
  • Vera, Mar
  • Jaen, Angels
  • Mena, Alvaro
  • Jarrin Vera, Inmaculada
  • Diaz Franco, Asuncion
  • CoRIS-HIV Biobank
Background: To estimate the prevalence of recent infection (RI) among people newly diagnosed with HIV in Spain using a representative sample collected by the AIDS Research Network cohort (CoRIS) during 2015-2016. Methods: Stratified sampling of CoRIS data was used with proportional allocation by mode of transmission of new HIV diagnoses notified to National Surveillance System. Samples used were from patients in the CoRIS cohort with available stored plasma collected within 6 months after diagnosis. Weighted methods were used to estimate the prevalence of RI and multivariate logistic regression models were used to determine associated factors. Results: Of the 669 individuals included, 55.1% were men who had sex with men (MSM), 24.6% were heterosexual, and 20.3% were non-MSM non-heterosexual. The weighted prevalence of RI was 11.8% (95% Confidence interval [CI] 9.4-14.8%) overall, 15.5% (12.2-19.4%) among MSM, 6.3% (3.9-10.0%) among heterosexual, and 8.6% (3.2-20.9%) in non-MSM non-heterosexual persons. Factors associated with prevalence of RI were: MSM (OR 2.05; 95% CI 1.02-4.14) vs. heterosexual, being Spanish (OR 2.92; 1.36-6.26) or European (OR 3.42; 1.28-9.13) vs. Latin American, having a secondary or higher education level (OR 3.08; 0.95-1.00) vs. primary, and having a CD4 count of 350-499 (OR 3.26; 1.46-7.30) or >500 (OR 6.26; 2.92-13.39) vs. <350 cells/mm3. Conclusions: In the absence of direct data from surveillance systems, the use of cohort data is a very valuable option for identifying the prevalence of RI at national level. This is the first nationwide study carried out in Spain to determine the prevalence of RI using an avidity assay.
Repisalud
Publicación Artículo científico (JournalArticle)

Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions

  • Sobrino-Vegas, Paz
  • Monge Corella, Susana
  • Serrano-Villar, Sergio
  • Gutiérrez, Félix
  • Blanco, José Ramón
  • Santos, Ignacio
  • Del Romero, Jorge
  • Segura, Ferrán
  • Portilla, Joaquín
  • Guillén, Santiago Moreno
  • Amo, Julia del
OBJECTIVES: We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004-2011 in a cohort of HIV-positive persons in Spain. METHODS: CoRIS is a multicentre, open and prospective cohort recruiting adult HIV-positive patients naïve to antiretroviral therapy. We analysed patients with at least one negative and one follow-up HCV serology. Incidence Rates (IR) were calculated and multivariate Poisson regression was used to estimate adjusted Rates Ratios (aIRR). RESULTS: Of 2112 subjects, 53 HCV diagnoses were observed, IR = 0.93/100 py (95%CI: 0.7-1.2). IR increased from 0.88 in 2004-05 to 1.36 in 2010-11 (aIRR = 1.55; 95%CI: 0.37-6.55). In men who have sex with men (MSM) from 0.76 to 1.10 (aIRR = 1.45; 95%CI: 0.31-6.82); in heterosexual (HTX) subjects from 1.19 to 1.28 (aIRR = 1.08; 95%CI: 0.11-10.24). HCV seroconversion rates decreased from 1.77 to 0.65 (aIRR = 0.37; 95%CI: 0.12-1.11); in MSM from 1.06 to 0.49 (aIRR = 0.46; 95%CI: 0.09-2.31); in HTX from 2.55 to 0.59 (aIRR = 0.23; 95%CI: 0.06-0.98). HCV infection risk was higher for injecting drug users (IDU) compared to HTX (aIRR = 9.63;95%CI: 2.9-32.2); among MSM, for subjects aged 40-50 compared to 30 or less (IRR = 3.21; 95%CI: 1.7-6.2); and among HTX, for female sex (aIRR = 2.35; 95%CI: 1.03-5.34) and <200 CD4-count (aIRR = 2.39; 95%CI: 0.83-6.89). CONCLUSION: We report increases in HCV diagnoses rates which seem secondary to intensification of HCV follow-up testing but not to rises in HCV infection rates. HCV IR is higher in IDU. In MSM, HCV IR increases with age. Among HTX, HCV IR is higher in women and in subjects with impaired immunological situation.
Repisalud
Publicación Artículo científico (JournalArticle)

VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients

  • Jimenez-Sousa, Maria Angeles
  • Jiménez, José Luis
  • Fernandez-Rodriguez, Amanda
  • Brochado-Kith, Oscar
  • Bellón, José María
  • Gutierrez, Félix
  • Díez, Cristina
  • Bernal-Morell, Enrique
  • Viciana, Pompeyo
  • Muñoz-Fernández, María Ángeles
  • Resino, Salvador
BACKGROUND: Vitamin D is a fundamental regulator of host defenses by activating genes related to innate and adaptive immunity. In this study, we analyzed the association among single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene, with clinical patterns of AIDS progression in antiretroviral treatment (ART)-naïve HIV-infected patients. METHODS: We conducted a retrospective study in 667 HIV-infected patients, who were classified within three groups according to their AIDS progression pattern (183 long-term non-progressors (LTNPs), 334 moderate progressors (MPs), and 150 rapid progressors (RPs)). Five VDR SNPs (rs11568820, rs4516035, rs2228570, rs1544410, and rs7975232) were genotyped using Agena Bioscience's MassARRAY platform. RESULTS: Significant association results were found for rs2228570. Within all HIV patients, the presence of T allele at VDR rs2228570 SNP was protective against AIDS progression (ordinal outcome) under additive (adjusted odds ratio (aOR) = 0.75; p = 0.009), dominant (aOR = 0.69; p = 0.015), and codominant (aOR = 0.56; p = 0.017) inheritance models. In addition, the same allele was protective under additive and codominant inheritance models when we compared with LTNPs vs. RPs [aOR = 0.64 (p = 0.019) and aOR = 0.37 (p = 0.018), respectively] and when we compared MPs vs. RPs [aOR = 0.72 (p = 0.035) and aOR = 0.45 (p = 0.028), respectively]. CONCLUSIONS: The VDR rs2228570 T allele was related to a lower AIDS progression pattern in ART-naïve HIV-infected patients. These findings expand upon the knowledge about HIV pathogenesis in untreated HIV-infected patients with different clinical outcomes.
Repisalud
Publicación Artículo científico (JournalArticle)

Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain

  • Fernandez-Garcia, Aurora
  • Delgado, Elena
  • Cuevas, Maria Teresa
  • Vega Rocha, Yolanda
  • Montero, Vanessa
  • Sánchez, Mónica
  • Carrera, Cristina
  • López-Álvarez, María José
  • Miralles, Celia
  • Pérez-Castro, Sonia
  • Cilla, Gustavo
  • Hinojosa, Carmen
  • Perez-Alvarez, Lucia
  • Thomson, Michael M
HIV-1 exhibits a characteristically high genetic diversity, with the M group, responsible for the pandemic, being classified into nine subtypes, 72 circulating recombinant forms (CRFs) and numerous unique recombinant forms (URFs). Here we characterize the near full-length genome sequence of an HIV-1 BG intersubtype recombinant virus (X3208) collected in Galicia (Northwest Spain) which exhibits a mosaic structure coincident with that of a previously characterized BG recombinant virus (9601_01), collected in Germany and epidemiologically linked to Portugal, and different from currently defined CRFs. Similar recombination patterns were found in partial genome sequences from three other BG recombinant viruses, one newly derived, from a virus collected in Spain, and two retrieved from databases, collected in France and Portugal, respectively. Breakpoint coincidence and clustering in phylogenetic trees of these epidemiologically-unlinked viruses allow to define a new HIV-1 CRF (CRF73_BG). CRF73_BG shares one breakpoint in the envelope with CRF14_BG, which circulates in Portugal and Spain, and groups with it in a subtype B envelope fragment, but the greatest part of its genome does not appear to derive from CRF14_BG, although both CRFs share as parental strain the subtype G variant circulating in the Iberian Peninsula. Phylogenetic clustering of partial pol and env segments from viruses collected in Portugal and Spain with X3208 and 9691_01 indicates that CRF73_BG is circulating in both countries, with proportions of around 2-3% Portuguese database HIV-1 isolates clustering with CRF73_BG. The fact that an HIV-1 recombinant virus characterized ten years ago as a URF has been shown to represent a CRF suggests that the number of HIV-1 CRFs may be much greater than currently known.
Repisalud
Publicación Artículo científico (JournalArticle)

Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets

  • Bedoya, Luis M
  • Beltran, Manuela
  • García-Pérez, Javier
  • Obregon-Calderon, Patricia
  • Callies, Oliver
  • Jímenez, Ignacio A
  • Bazzocchi, Isabel L
  • Alcamí, José
Current research on antiretroviral therapy is mainly focused in the development of new formulations or combinations of drugs belonging to already known targets. However, HIV-1 infection is not cured by current therapy and thus, new approaches are needed. Bevirimat was developed by chemical modification of betulinic acid, a lupane-type pentacyclic triterpenoid (LPT), as a first-in-class HIV-1 maturation inhibitor. However, in clinical trials, bevirimat showed less activity than expected because of the presence of a natural mutation in Gag protein that conferred resistance to a high proportion of HIV-1 strains. In this work, three HIV-1 inhibitors selected from a set of previously screened LPTs were investigated for their targets in the HIV-1 replication cycle, including their maturation inhibitor effect. LPTs were found to inhibit HIV-1 infection acting as promiscuous compounds with several targets in the HIV-1 replication cycle. LPT12 inhibited HIV-1 infection mainly through reverse transcription, integration, viral transcription, viral proteins (Gag) production and maturation inhibition. LPT38 did it through integration, viral transcription or Gag production inhibition and finally, LPT42 inhibited reverse transcription, viral transcription or Gag production. The three LPTs inhibited HIV-1 infection of human primary lymphocytes and infections with protease inhibitors and bevirimat resistant HIV-1 variants with similar values of IC50. Therefore, we show that the LPTs tested inhibited HIV-1 infection through acting on different targets depending on their chemical structure and the activities of the different LPTs vary with slight structural alterations. For example, of the three LPTs under study, we found that only LPT12 inhibited infectivity of newly-formed viral particles, suggesting a direct action on the maturation process. Thus, the multi-target behavior gives a potential advantage to these compounds since HIV-1 resistance can be overcome by modulating more than one target.
Repisalud
Publicación Artículo científico (JournalArticle)

4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat

  • de la Torre-Tarazona, Humberto Erick
  • Jiménez, R
  • Bueno, P
  • Camarero-Serrano, Sara
  • Román, L
  • Fernández-García, J L
  • Beltran, Manuela
  • Nothias, L F
  • Cachet, X
  • Paolini, J
  • Litaudon, M
  • Alcamí, José
  • Bedoya, Luis M
Latent HIV reservoirs are the main obstacle to eradicate HIV infection. One strategy proposes to eliminate these viral reservoirs by pharmacologically reactivating the latently infected T cells. We show here that a 4-deoxyphorbol ester derivative isolated from Euphorbia amygdaloides ssp. semiperfoliata, 4β-dPE A, reactivates HIV-1 from latency and could potentially contribute to decrease the viral reservoir. 4β-dPE A shows two effects in the HIV replication cycle, infection inhibition and HIV transactivation, similarly to other phorboids PKC agonists such PMA and prostratin and to other diterpene esters such SJ23B. Our data suggest 4β-dPE A is non-tumorigenic, unlike the related compound PMA. As the compounds are highly similar, the lack of tumorigenicity by 4β-dPE A could be due to the lack of a long side lipophilic chain that is present in PMA. 4β-dPE activates HIV transcription at nanomolar concentrations, lower than the concentration needed by other latency reversing agents (LRAs) such as prostratin and similar to bryostatin. PKCθ/MEK activation is required for the transcriptional activity, and thus, anti-latency activity of 4β-dPE A. However, CD4, CXCR4 and CCR5 receptors down-regulation effect seems to be independent of PCK/MEK, suggesting the existence of at least two different targets for 4β-dPE A. Furthermore, NF-κb transcription factor is involved in 4β-dPE HIV reactivation, as previously shown for other PKCs agonists. We also studied the effects of 4β-dPE A in combination with other LRAs. When 4β-dPE A was combined with another PKC agonists such as prostratin an antagonic effect was achieved, while, when combined with an HDAC inhibitor such as vorinostat, a strong synergistic effect was obtained. Interestingly, the latency reversing effect of the combination was synergistically diminishing the EC50 value but also increasing the efficacy showed by the drugs alone. In addition, combinations of 4β-dPE A with antiretroviral drugs as CCR5 antagonist, NRTIs, NNRTIs and PIs, showed a consistent synergistic effect, suggesting that the combination would not interefer with antiretroviral therapy (ART). Finally, 4β-dPE A induced latent HIV reactivation in CD4 + T cells of infected patients under ART at similar levels than the tumorigenic phorbol derivative PMA, showing a clear reactivation effect. In summary, we describe here the mechanism of action of a new potent deoxyphorbol derivative as a latency reversing agent candidate to decrease the size of HIV reservoirs.
Repisalud
Publicación Artículo científico (JournalArticle)

Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen

  • Prado, Silvia
  • Beltran, Manuela
  • Coiras, Mayte
  • Bedoya, Luis M
  • Alcamí, José
  • Gallego, José
New antiretroviral agents with alternative mechanisms are needed to complement the combination therapies used to treat HIV-1 infections. Here we report the identification of bioavailable molecules that interfere with the gene expression processes of HIV-1. The compounds were detected by screening a small library of FDA-approved drugs with an assay based on measuring the displacement of Rev, and essential virus-encoded protein, from its high-affinity RNA binding site. The antiretroviral activity of two hits was based on interference with post-integration steps of the HIV-1 cycle. Both hits inhibited RRE-Rev complex formation in vitro, and blocked LTR-dependent gene expression and viral transcription in cellular assays. The best compound altered the splicing pattern of HIV-1 transcripts in a manner consistent with Rev inhibition. This mechanism of action is different from those used by current antiretroviral agents. The screening hits recognized the Rev binding site in the viral RNA, and the best compound did so with substantial selectivity, allowing the identification of a new RNA-binding scaffold. These results may be used for developing novel antiretroviral drugs.
Repisalud
Publicación Artículo científico (JournalArticle)

Estudio cycEVA: casos y controles para la estimación de la efectividad de la vacuna antigripal en España, 2008-2013, cycEVA study: case control study measuring influenza vaccine effectiveness in Spain, 2008-2013

  • Jimenez-Jorge, Silvia
  • Mateo-Ontañon, Salvador de
  • Savulescu, Camelia
  • Delgado-Sanz, Concepcion
  • Pozo Sanchez, Francisco
  • Garcia-Cenoz, Manuel
  • Castilla Catalán, Jesús
  • Vega Alonso, Tomás
  • Rodríguez Gay, Carolina
  • Quiñones-Rubio, Carmen
  • Martínez Ochoa, Eva
  • Vanrell Berga, Juana María
  • Giménez Duran, Jaume
  • Castrillejo Pérez, Daniel
  • Altzíbar Arotzena, Jone Miren
  • González Carril, Fernando
  • Ramos Aceitero, Julián Mauro
  • Serrano Martin, María del Carmen
  • Martínez i Mateo, Ana
  • Torner Gràcia, Nuria
  • Pérez Morilla, Esteban
  • Gallardo García, Virtudes
  • Larrauri, Amparo
[ES] Fundamentos: Desde 2008-09 la efectividad de la vacuna (EV) antigripal en España se estima con el estudio de casos y controles para la evaluación de la EV antigripal (cycEVA), componente español de la red europea (Influenza-Monitoring Vaccine Effectiveness (I-MOVE). El objetivo es describir la evolución del estudio cycEVA durante las cinco temporadas del período 2008/09-; 2012/13. Métodos: Se analizaron los siguientes indicadores: 1) participación de los médicos/pediatras centinela (MP); 2) población y periodo de estudio, 3) calidad de los datos y 4) difusión de los resultados mediantes publicaciones. Se calculó el porcentaje anual de cambio constante de los indicadores analizándose su tendencia mediante el test de Cochran-Armitage. Resultados: El número de MP participantes aumentó de 164 en 2008-09 hasta 246 en ediciones posteriores. El porcentaje de médicos que reclutaron al menos un paciente experimentó un cambio anual significativo (PCA) del 15,33%. El porcentaje de pacientes reclutados incluidos en el análisis aumentó del 77% en 2008-09 a más del 95% en las siguientes ediciones (PCA=5,91%). El porcentaje de casos y controles participantes en cycEVA sobre el total de pacientes que contribuyeron al estudio europeo I-MOVE osciló entre el 23% en la edición piloto y 30% en la temporada 2011-12. Los resultados finales se difundieron en revistas científicas con un factor de impacto situado en el cuartil 2 y en 2010-11 y 2011-12 se publicaron resultados preliminares en revistas con un factor de impacto situado en el cuartil 1 (97 citas). Conclusiones: La experiencia del estudio cycEVA se reflejó en una mejora en la oportunidad e impacto de sus resultados, cruciales para orientar las recomendaciones anuales de vacunación antigripal. [EN] Background: In Spain, influenza vaccine effectiveness (EV) is estimated since 2008-09 season through the cycEVA case-control study, the Spanish component of the European I-MOVE (Monitoring Influenza Vaccine Effectiveness in the EU/EEA) network. We aimed at describing cycEVA performance in its five consolidated editions 2008/09 -; 2012/13. Methods: During the study period the following indicators were analysed: 1) the participation of sentinel general practitioners and pediatricians (MP), 2) the population studied and the study period, 3) the data quality and 4) the dissemination of the cycEVA results. Trend analysis of the indicators was done using the Cochran-Armitage test to compute the Annual Percentage Change (PCA). Results: The number of participating MP increased from 164 in 2008-09 to 246 in the following editions. The percentage of MP recruiting at least one patient increased significantly annually (PCA = 15.33%). The percentage of recruited patients included into the analysis increased (PCA=5.91%) from 77% in 2008-09 to more than 95% in the following editions. The percentage of cycEVA patients contributing to the I-MOVE study ranged between 23% and 30% in the pilot and 2011-12 editions respectively.. Final results were disseminated in quartile 2 peer-reviewed journals and 2010-11 and 2011-12 preliminary EV estimates were published in quartile 1 journals. cycEVA publications received 97 citations. Conclusion: cycEVA study achieved more quality information, timely EV estimates and a higher impact of the results.
Repisalud
Publicación Artículo científico (JournalArticle)

Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America

  • Ambia, Julie
  • Ingle, Suzanne M
  • McGinnis, Kathleen
  • Pantazis, Nikos
  • Silverberg, Michael J
  • Wittkop, Linda
  • Kusejko, Katharina
  • Crane, Heidi
  • van Sighem, Ard
  • Sarcletti, Mario
  • Cozzi-Lepri, Alessandro
  • Domingo, Pere
  • Jarrin Vera, Inmaculada
  • Wyen, Christoph
  • Hessamfar, Mojgan
  • Zhang, Lei
  • Cavassini, Matthias
  • Berenguer, Juan
  • Sterling, Timothy R
  • Reiss, Peter
  • Abgrall, Sophie
  • Gill, M John
  • Justice, Amy
  • Sterne, Jonathan A C
  • Trickey, Adam
Background: Predicting cause-specific mortality among people with HIV (PWH) could facilitate targeted care to improve survival. We assessed discrimination of the Veterans Aging Cohort Study (VACS) Index 2.0 in predicting cause-specific mortality among PWH on antiretroviral therapy (ART). Methods: Using Antiretroviral Therapy Cohort Collaboration data for PWH who initiated ART between 2000 and 2018, VACS Index 2.0 scores (higher scores indicate worse prognosis) were calculated around a randomly selected visit date at least 1 year after ART initiation. Missingness in VACS Index 2.0 variables was addressed through multiple imputation. Cox models estimated associations between VACS Index 2.0 and causes of death, with discrimination evaluated using Harrell's C-statistic. Absolute mortality risk was modelled using flexible parametric survival models. Results: Of 59 741 PWH (mean age: 43 years; 80% male), the mean VACS Index 2.0 at baseline was 41 (range: 0-129). For 2425 deaths over 168 162 person-years follow-up (median: 2.6 years/person), AIDS (n = 455) and non-AIDS-defining cancers (n = 452) were the most common causes. Predicted 5-year mortality for PWH with a mean VACS Index 2.0 score of 38 at baseline was 1% and approximately doubled for every 10-unit increase. The 5-year all-cause mortality C-statistic was .83. Discrimination with the VACS Index 2.0 was highest for deaths resulting from AIDS (0.91), liver-related (0.91), respiratory-related (0.89), non-AIDS infections (0.87), and non-AIDS-defining cancers (0.83), and lowest for suicides/accidental deaths (0.65). Conclusions: For deaths among PWH, discrimination with the VACS Index 2.0 was highest for deaths with measurable physiological causes and was lowest for suicide/accidental deaths.
Repisalud
Publicación Artículo científico (JournalArticle)

Psychological distress in women and men living with HIV in Spain: a cross-sectional telephone survey

  • Garriga, Cesar
  • Gutiérrez Trujillo, Lourdes
  • Del Romero, Jorge
  • Montero, Marta
  • Pérez-Elías, María-Jesús
  • Culqui, Dante Roger
  • Gutierrez, Félix
  • Gómez-Sirvent, Juan Luis
  • Peña-Monje, Alejandro
  • Blanco, José Ramón
  • Rodriguez-Arenas, Maria de los Angeles
Background: Psychological distress includes a broader range of experiences, varying from less severe symptoms of depression and anxiety to severe psychiatric disease. Global estimates for depression and anxiety in 2017 were 3.4% and 3.8%, respectively. While for people living with HIV, global estimates were 16% and 33%, respectively. Objective: We aimed to determine the prevalence of psychological distress by gender and associated characteristics in patients living with HIV. Methods: A cross-sectional study was conducted within the Spanish HIV Research Network CoRIS. Participants were interviewed by telephone between 2010 and 2014 about their psychological distress, sociodemographics, drug consumption, self-perceived health and combined antiretroviral therapy (cART) adherence. Laboratory tests and medical history details were collected from CoRIS. Logistic regression was used to identify characteristics associated with psychological distress. Findings: We interviewed 99 women and 464 men, both living with HIV. A greater proportion of women (51, 51.5%) reported psychological distress than men (179, 38.6%; p<0.01). Non-adherence to cART (OR 4.6 and 2.3, 95% CI 1.4‒15.1 and 1.3‒4.2) and non-use of cART (8.4 and 1.8, 2.2‒32.4 and 1.1‒2.8) were related to psychological distress in women and men, respectively. Spending little time in leisure-based physical activity was related to psychological distress in women (3.1, 1.1‒9.0). Living alone (2.0, 1.3‒3.0) and being unemployed (2.3, 1.4‒3.6) were related to psychological distress in men. Conclusions and clinical implications: As people living with HIV have a high prevalence of psychological distress, their regular screening appointments should include psychological assessment. A gendered approach is needed to detect and manage psychological distress.
Repisalud
Publicación Artículo científico (JournalArticle)

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors

  • Díez-Fuertes, Francisco
  • de la Torre-Tarazona, Humberto Erick
  • Calonge, Esther
  • Pernas, Maria
  • Alonso-Socas, María Del Mar
  • Capa, Laura
  • García-Pérez, Javier
  • Sakuntabhai, Anavaj
  • Alcamí, José
The elite controller (EC)-long term non-progressor (LTNP) phenotype represent a spontaneous and advantageous model of HIV-1 control in the absence of therapy. The transcriptome of peripheral blood mononuclear cells (PBMCs) collected from EC-LTNPs was sequenced by RNA-Seq and compared with the transcriptomes from other phenotypes of disease progression. The transcript abundance estimation combined with the use of supervised classification algorithms allowed the selection of 20 genes and pseudogenes, mainly involved in interferon-regulated antiviral mechanisms and cell machineries of transcription and translation, as the best predictive genes of disease progression. Differential expression analyses between phenotypes showed an altered calcium homeostasis in EC-LTNPs evidenced by the upregulation of several membrane receptors implicated in calcium-signaling cascades and intracellular calcium-mobilization and by the overrepresentation of NFAT1/Elk-1-binding sites in the promoters of the genes differentially expressed in these individuals. A coordinated upregulation of host genes associated with HIV-1 reverse transcription and viral transcription was also observed in EC-LTNPs -i.e. p21/CDKN1A, TNF, IER3 and GADD45B. We also found an upregulation of ANKRD54 in EC-LTNPs and viremic LTNPs in comparison with typical progressors and a clear alteration of type-I interferon signaling as a consequence of viremia in typical progressors before and after receiving antiretroviral therapy.
Repisalud
Publicación Artículo científico (JournalArticle)

Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.

  • Diago-Sempere, Elena
  • Bueno, José Luis
  • Sancho-López, Aránzazu
  • Múñez Rubio, Elena
  • Torres, Ferrán
  • Malo de Molina, Rosa
  • Fernández-Cruz, Ana
  • Salcedo de Diego, Isabel
  • Velasco-Iglesias, Ana
  • Payares-Herrera, Concepción
  • Casas Flecha, Inmaculada
  • Avendaño-Solá, Cristina
  • Duarte Palomino, Rafael
  • Ramos-Martínez, Antonio
  • Ruiz-Antorán, Belén
COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. At the time this clinical trial was planned, there were no available vaccine or therapeutic agents with proven efficacy, but the severity of the condition prompted the use of several pharmacological and non-pharmacological interventions. It has long been hypothesized that the use of convalescent plasma (CP) from infected patients who have developed an effective immune response is likely to be an option for the treatment of patients with a variety of severe acute respiratory infections (SARI) of viral etiology. The aim of this study is to assess the efficacy and safety of convalescent plasma in adult patients with severe COVID-19 pneumonia. The ConPlas-19 study is a multicenter, randomized, open-label controlled trial. The study has been planned to include 278 adult patients hospitalized with severe COVID-19 infection not requiring mechanical ventilation (invasive or non-invasive). Subjects are randomly assigned in a 1:1 ratio (139 per treatment arm), stratified by center, to receive intravenously administered CP (single infusion) plus SOC or SOC alone, and are to be followed for 30 days. The primary endpoint of the study is the proportion of patients that progress to category 5, 6, or 7 (on the 7-point ordinal scale proposed by the WHO) at day 15. Interim analyses for efficacy and/or futility will be conducted once 20%, 40%, and 60% of the planned sample size are enrolled and complete D15 assessment. This clinical trial is designed to evaluate the efficacy and safety of passive immunotherapy with convalescent plasma for the treatment of adult patients hospitalized with COVID-19. The results of this study are expected to contribute to establishing the potential place of CP in the therapeutics for a new viral disease. ClinicalTrials.gov NCT04345523 . Registered on 30 March, 2020. First posted date: April 14, 2020.
Repisalud
Publicación Artículo científico (JournalArticle)

Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study

  • Jimenez-Jorge, Silvia
  • Pozo Sanchez, Francisco
  • Mateo-Ontañon, Salvador de
  • Delgado-Sanz, Concepcion
  • Casas Flecha, Inmaculada
  • Garcia-Cenoz, Manuel
  • Castilla Catalán, Jesús
  • Sancho, R
  • Etxebarriarteun-Aranzabal, L
  • Quinones, C
  • Martinez, E
  • Vega, T
  • Garcia, A
  • Gimenez, J
  • Vanrell, Juana María
  • Castrillejo, D
  • Larrauri, Amparo
Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.
Repisalud
Publicación Artículo científico (JournalArticle)

Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012

  • Jimenez-Jorge, Silvia
  • Mateo-Ontañon, Salvador de
  • Pozo Sanchez, Francisco
  • Casas Flecha, Inmaculada
  • Garcia-Cenoz, Manuel
  • Castilla Catalán, Jesús
  • Gallardo, V
  • Perez, E
  • Vega, T
  • Rodriguez, C
  • Quinones, C
  • Martinez, E
  • Gimenez, J
  • Vanrell, Juana María
  • Castrillejo, D
  • Serrano, Mc
  • Ramos, Jm
  • Larrauri, Amparo
We present early estimates of influenza vaccine effectiveness (VE) in the population targeted for vaccination, during 25 December 2011 to 19 February 2012. The adjusted VE was 55% (95% CI: 3 to 79) against any type of influenza virus and 54% (95% CI: 1 to 79) against influenza A(H3N2) virus. This suggests a moderate protective effect of the vaccine in the targeted population in a late influenza epidemic with limited match between vaccine and circulating strains.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Elite controllers and lessons learned for HIV-1 cure

  • Lopez-Galindez, Luis Cecilio
  • Pernas, Maria
  • Casado, Concepcion
  • Olivares, Isabel
  • Lorenzo-Redondo, Ramon
Following the success of HIV-1 antiviral treatment that maintains undetectable levels of viral replication and lack of clinical progression, the design of an HIV-1 cure for patients became the next objective. The success of the treated individuals together with the identification of subjects that spontaneously control the clinical progression for long periods, such as long-term non-progressors (LTNPs) and particularly LTNP Elite Controllers (LTNP EC) have shed hope for the feasibility of a potential cure. Although a successful cure has not been attained yet, these patients have provided critical information on the mechanisms involved in the clinical control such as host genetic factors, as well as strong immune responses against the virus. Less attention has been paid to virological factors, particularly the association of the genetic variability and the control of viral infection. Considering all these studies, it has become clear that a combination of several host, immune and viral factors is needed to attain control of the viral replication control and the non-progressor clinical phenotype. Because this control can be reached through different combinations of factors, this group of individuals is not homogenous. As HIV-1 cure has been shown to be extremely difficult to achieve, a more feasible objective is the functional cure of the viral infection. After the analysis of multiple studies on the mechanisms of control in LTNP EC, we found subjects with various host protective factors and prolonged viral control. These subjects present a complete lack of evolution after more than 20-30 years of infection, stable levels of CD4+ cells (>400-500 cells/μl), a strong immune response, and no signs of clinical progression. We propose that individuals with these characteristics could have attained a functional cure of the HIV-1 infection.
Repisalud
Publicación Artículo científico (JournalArticle)

Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study

  • Savulescu, Camelia
  • Jimenez-Jorge, Silvia
  • Mateo-Ontañon, Salvador de
  • Ledesma, Juan
  • Pozo Sanchez, Francisco
  • Casas Flecha, Inmaculada
  • Larrauri, Amparo
We present preliminary results of a case-control study to estimate influenza vaccine effectiveness in Spain, from week 50 of 2010 to week 6 of 2011. The adjusted effectiveness of the vaccine in preventing laboratory-confirmed influenza due to any type of influenza virus was 50% (95% CI: -6 to 77%) for the trivalent seasonal vaccine and 72% (95% CI: 7 to 92%) for both trivalent seasonal and monovalent pandemic vaccines, suggesting a protective effect of seasonal vaccination lower than that reported for the previous season.
Repisalud
Publicación Artículo científico (JournalArticle)

Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study.

  • Garcia-Broncano, Pilar
  • Medrano, Luz Maria
  • Berenguer, Juan
  • Brochado-Kith, Oscar
  • González-García, Juan
  • Jimenez-Sousa, Maria Angeles
  • Quereda, Carmen
  • Sanz, José
  • Téllez, María Jesús
  • Díaz, Laura
  • Jiménez, José Luis
  • Resino, Salvador
Objective: There are a lack of consistency among articles in regards to the evolution of peripheral immune biomarkers after HCV therapy. We aimed to detect the most relevant changes in peripheral immune biomarkers among HIV/HCV-coinfected patients who achieved sustained virologic response (SVR) following peg-IFN-α/ribavirin therapy and to evaluate its normalization with respect to an HIV-monoinfected control group. Methods: We performed a prospective cohort study in 99 HIV/HCV-coinfected patients with samples at baseline (HIV/HCV-b-group) and at week 24 after SVR (HIV/HCV-f-group). We also used a control group of 39 HIV-monoinfected patients (HIV-group) negative for HCV and HBV infections, and who had undetectable HIV viral load and CD4+ >500 cells/mm3. Peripheral T cell subsets were assessed by flow cytometry and plasma biomarkers by immunoassays. Results: HIV/HCV-coinfected patients had higher values of in IL-10, IL-4, IP-10, IL-8, IL-1β, IL-18, IL-6, IFN-γ, IL-12p70, TNF-α, sVCAM-1, sICAM-1, and sTNFR-1 than HIV control subjects, both at the beginning and at the end of follow-up. Moreover, three biomarkers (CD4+CD38+, telomere length, and IL-1RA) were normalized in relation to the control group at the end of follow-up (the HIV/HCV-b group had higher values and the HIV/HCV-f group had similar values as the HIV-group). Additionally, LPS, IL-2, and IL-17A levels were higher in the HIV/HCV-f group than the HIV-group (24 weeks after SVR). During the follow-up, HIV/HCV-coinfected patients had a significant decrease by the end of follow-up in CD8+CD45RA-CD28+, CD4+CD38+, CD4+CD25+CD127-/low, CD4+CD25+CD127-/low CD45RA-, FABP2, LBP, IP-10, sVCAM1. Only CD4+CD38+ was normalized. Conclusion: HIV/HCV-patients showed a slight improvement in the overall profile of immune biomarkers after achieving SVR.
Repisalud
Publicación Artículo científico (JournalArticle)

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients

  • Ramirez de Arellano, Eva
  • Díez-Fuertes, Francisco
  • Aguilar, Francisco
  • de la Torre-Tarazona, Humberto Erick
  • Sanchez-Lara, Susana
  • Lao, Yolanda
  • Vicario, José Luis
  • García, Felipe
  • González-García, Juan
  • Pulido, Federico
  • Gutierrez-Rodero, Félix
  • Moreno, Santiago
  • Iribarren, Jose Antonio
  • Viciana, Pompeyo
  • Vilches, Carlos
  • Ramos, Manuel
  • Capa, Laura
  • Alcamí, José
  • Val, Margarita del
Certain host genetic variants, especially in the human leucocyte antigen (HLA) region, are associated with different progression of HIV-1-induced diseases and AIDS. Long term non progressors (LTNP) represent only the 2% of infected patients but are especially relevant because of their efficient HIV control. In this work we present a global analysis of genetic data in the large national multicenter cohort of Spanish LTNP, which is compared with seronegative individuals and HIV-positive patients. We have analyzed whether several single-nucleotide polymorphisms (SNPs) including in key genes and certain HLA-A and B alleles could be associated with a specific HIV phenotype. A total of 846 individuals, 398 HIV-1-positive patients (213 typical progressors, 55 AIDS patients, and 130 LTNPs) and 448 HIV-negative controls, were genotyped for 15 polymorphisms and HLA-A and B alleles. Significant differences in the allele frequencies among the studied populations identified 16 LTNP-associated genetic factors, 5 of which were defined for the first time as related to LTNP phenotype: the protective effect of HLA-B39, and the detrimental impact of HLA-B18, -A24, -B08 and -A29. The remaining eleven polymorphisms confirmed previous publications, including the protective alleles HLA-B57, rs2395029 (HCP5), HLA bw4 homozygosity, HLA-B52, HLA-B27, CCR2 V64I, rs9264942 (HLA-C) and HLA-A03; and the risk allele HLA bw6 homozygosity. Notably, individual Spanish HIV-negative individuals had an average of 0.12 protective HLA alleles and SNPs, compared with an average of 1.43 protective alleles per LTNP patient, strongly suggesting positive selection of LTNP. Finally, stratification of LTNP according to viral load showed a proportional relationship between the frequency of protective alleles with control of viral load. Interestingly, no differences in the frequency of protection/risk polymorphisms were found between elite controllers and LTNPs maintaining viral loads <2.000 copies/mL throughout the follow-up.
Repisalud
Publicación Artículo científico (JournalArticle)

LIN28 upregulation in primary human T cells impaired CAR T antitumoral activity

  • García-Rodriguez, Patricia
  • Hidalgo, Laura
  • Rodriguez-Milla, Miguel A
  • Somovilla-Crespo, Beatriz
  • Garcia-Castro, Javier
LIN28, a highly conserved RNA-binding protein that acts as a posttranscriptional modulator, plays a vital role in the regulation of T-cell development, reprogramming, and immune activity in infectious diseases and T-cell-based immunotherapies. LIN28 inhibit the expression of miRNAs, the most prevalent family of miRNAs in lymphocytes. Recently it has been suggested that enhances murine anti-tumor immune responses. Here, we investigated the impact of LIN28 upregulation on human T cell functions, focusing on its influence on CAR T cell therapy. LIN28 lentiviral transduction of human T cells led to a stable expression of LIN28 that significantly downregulated the miRNA family without affecting cell viability or expansion potential. LIN28 overexpression maintained human T cell phenotype markers and functionality but impaired the antitumoral cytotoxicity of NKG2D-CAR T cells both and . These findings highlight the intricate relationship between LIN28/ axis and human T cell functionality, including in CAR T cell therapy.
Repisalud
Publicación Artículo científico (JournalArticle)

Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants

  • García-Pérez, Javier
  • Borobia, Alberto M
  • Perez-Olmeda, Mayte
  • Portolés, Antonio
  • Castaño, Luis
  • Campins-Artí, Magdalena
  • Bertrán, María Jesús
  • Bermejo, Mercedes
  • Arribas, José Ramón
  • López, Andrea
  • Ascaso-Del-Rio, Ana
  • Arana-Arri, Eunate
  • Fuentes Camps, Inmaculada
  • Vilella, Anna
  • Cascajero Díaz, Almudena
  • García-Morales, María Teresa
  • Castillo de la Osa, María
  • Pérez Ingidua, Carla
  • Lora, David
  • Jiménez Santana, Paloma
  • Pino-Rosa, Silvia del
  • Gómez de la Cámara, Agustín
  • de la Torre-Tarazona, Humberto Erick
  • Calonge, Esther
  • Cruces Fernández, Raquel
  • Belda-Iniesta, Cristobal
  • Alcamí, José
  • Frías, Jesús
  • Carcas, Antonio J
  • Díez-Fuertes, Francisco
  • CombiVacS Study Group
CombiVacS study has demonstrated a strong immune response of the heterologous ChAdOx1-S/BNT162b2 vaccine combination. The primary outcomes of the study were to assess the humoral immune response against SARS-CoV-2, 28 days after a third dose of a mRNA vaccine, in subjects that received a previous prime-boost scheme with ChAdOx1-S/BNT162b2. Secondary outcomes extended the study to 3 and 6 months. The third vaccine dose of mRNA-1273 in naive participants previously vaccinated with ChAdOx1-S/BNT162b2 regimen reached higher neutralizing antibodies titers against the variants of concern Delta and BA.1 lineage of Omicron compared with those receiving a third dose of BNT162b2 at day 28. These differences between BNT162b2 and mRNA-1273 arms were observed against the ancestral variant G614 at day 90. Suboptimal neutralizing response was observed against BQ.1.1, XBB.1.5/XBB.1.9, and JN.1 in a relevant proportion of individuals 180 days after the third dose, even after asymptomatic Omicron breakthrough infections. EudraCT (2021-001978-37); ClinicalTrials.gov (NCT04860739).
Repisalud
Publicación Artículo científico (JournalArticle)

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination

  • Jimenez-Jorge, Silvia
  • Mateo-Ontañon, Salvador de
  • Delgado-Sanz, Concepcion
  • Pozo Sanchez, Francisco
  • Casas Flecha, Inmaculada
  • Garcia-Cenoz, Manuel
  • Castilla Catalán, Jesús
  • Pérez, Esteban
  • Gallardo, Virtudes
  • Rodriguez, Carolina
  • Vega, Tomás
  • Quiñones, Carmen
  • Martínez, Eva
  • Vanrell, Juana María
  • Giménez, Jaume
  • Castrillejo, Daniel
  • Serrano, María del Carmen
  • Ramos, Julián Mauro
  • Larrauri, Amparo
BACKGROUND: In Spain, the influenza vaccine effectiveness (VE) was estimated in the last three seasons using the observational study cycEVA conducted in the frame of the existing Spanish Influenza Sentinel Surveillance System. The objective of the study was to estimate influenza vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza-like illness (ILI) among the target groups for vaccination in Spain in the 2011-2012 season. We also studied influenza VE in the early (weeks 52/2011-7/2012) and late (weeks 8-14/2012) phases of the epidemic and according to time since vaccination. METHODS: Medically attended patients with ILI were systematically swabbed to collect information on exposure, laboratory outcome and confounding factors. Patients belonging to target groups for vaccination and who were swabbed <8 days after symptom onset were included. Cases tested positive for influenza and controls tested negative for any influenza virus. To examine the effect of a late season, analyses were performed according to the phase of the season and according to the time between vaccination and symptoms onset. RESULTS: The overall adjusted influenza VE against A(H3N2) was 45% (95% CI, 0-69). The estimated influenza VE was 52% (95% CI, -3 to 78), 40% (95% CI, -40 to 74) and 22% (95% CI, -135 to 74) at 3.5 months, 3.5-4 months, and >4 months, respectively, since vaccination. A decrease in VE with time since vaccination was only observed in individuals aged ≥ 65 years. Regarding the phase of the season, decreasing point estimates were only observed in the early phase, whereas very low or null estimates were obtained in the late phase for the shortest time interval. CONCLUSIONS: The 2011-2012 influenza vaccine showed a low-to-moderate protective effect against medically attended, laboratory-confirmed influenza in the target groups for vaccination, in a late season and with a limited match between the vaccine and circulating strains. The suggested decrease in influenza VE with time since vaccination was mostly observed in the elderly population. The decreasing protective effect of the vaccine in the late part of the season could be related to waning vaccine protection because no viral changes were identified throughout the season.
Repisalud
Publicación Artículo científico (JournalArticle)

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

  • Bermejo, Mercedes
  • Lopez-Huertas, Maria Rosa
  • García-Pérez, Javier
  • Climent, Núria
  • Descours, Benjamin
  • Ambrosioni, Juan
  • Mateos, Elena
  • Rodriguez‑Mora, Sara
  • Rus-Bercial, Lucía
  • Benkirane, Monsef
  • Miró, José María
  • Plana, Montserrat
  • Alcamí, José
  • Coiras, Mayte
Massive activation of infected CD4+ T cells during acute HIV-1 infection leads to reservoir seeding and T-cell destruction. During T-cell activation, the antiviral effect of the innate factor SAMHD1 is neutralized through phosphorylation at T592, allowing HIV-1 infection. Dasatinib, a tyrosine kinase inhibitor currently used for treating chronic myeloid leukemia, has been described to control HIV-1 replication through its negative effect on T-cell proliferation and viral entry. We demonstrate that Dasatinib can actually interfere with SAMHD1 phosphorylation in human peripheral blood lymphocytes, preserving its antiviral activity against HIV-1. Dasatinib prevented SAMHD1 phosphorylation in vitro and ex vivo, impairing HIV-1 reverse transcription and proviral integration. This was the major mechanism of action because the presence of Vpx, which degrades SAMHD1, in HIV-1 virions impeded the inhibitory effect of Dasatinib on HIV-1 replication. In fact, infection with VSV-pseudotyped HIV-1 virions and fusion of BlaM-Vpr-containing HIV-1 viruses with activated PBMCs in the presence of Dasatinib suggested that Dasatinib was not acting at fusion level. Finally, PBMCs from patients on chronic treatment with Dasatinib showed a lower level of SAMHD1 phosphorylation in response to activating stimuli and low susceptibility to HIV-1 infection ex vivo. Consequently, Dasatinib is a compound currently used in clinic that preserves the antiviral function of SAMHD1. Using Dasatinib as adjuvant of antiretroviral therapy during early primary HIV-1 infection would contribute to reduce viral replication and spread, prevent reservoir seeding, and preserve CD4 counts and CTL responses. These events would create a more favorable virologic and immunologic environment for future interventional studies aiming at HIV-1 eradication.
Repisalud
Publicación Artículo científico (JournalArticle)

Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy

  • Medrano, Luz Maria
  • Gutiirrez-Rivas, Monica
  • Blanco, Julià
  • García, Marcial
  • Jimenez-Sousa, Maria Angeles
  • Pacheco, Yolanda María
  • Montero, Marta
  • Iribarren, José Antonio
  • Bernal, Enrique
  • Martínez, Onofre Juan
  • Benito, José Miguel
  • Rallón, Norma
  • Resino, Salvador
BACKGROUND: The mitochondrial DNA (mtDNA) seems to influence in a large number of diseases, including HIV infection. Moreover, there is a substantial inter-individual variability in the CD4+ recovery in HIV-infected patients on combination antiretroviral therapy (cART). Our study aimed to analyze the association between mtDNA haplogroups and CD4+ recovery in HIV-infected patients on cART. METHODS: This is a retrospective study of 324 naïve cART patients with CD4+ < 200 cells/mm3, who were followed-up during 24 months after initiating cART. All patients had undetectable HIV viral load during the follow-up. Besides, we included 141 healthy controls. MtDNA genotyping was performed by using Sequenom's MassARRAY platform. The primary outcome variable was the slope of CD4+ recovery. Patients were stratified into two groups by the median slope value of CD4+ (9.65 CD4+ cells/mm3/month). Logistic regression analyses were performed to calculate the odds of CD4+ recovery according to mtDNA haplogroups. RESULTS: Our study included European HIV-infected patients within the N macro-cluster. The baseline values of CD4+ T-cells were similar between groups of patients stratified by the P50th of the slope of CD4+ T-cells recovery. Patients in the low CD4+ T-cells recovery group were older (p = 0.001), but this variable was included in the multivariate models. When we analyzed the frequencies of mtDNA haplogroups, no significant differences between HIV-infected individuals and healthy controls were found. We did not find any significant association between mtDNA haplogroups and the slope of CD4+ T-cells recovery by linear regression analysis. However, Patients carrying haplogroup H had a higher odds of having a better CD4+ recovery (> 9.65 CD4+ cells/mm3/month) than patients without haplogroup H (p = 0.032). The adjusted logistic regression showed that patients carrying haplogroup H had a higher likelihood of achieving a CD4+ recovery > 9.65 CD4+ cells/mm3/month [adjusted odds ratio (aOR) = 1.75 (95% CI = 1.04; 2.95); p = 0.035]. CONCLUSIONS: European mitochondrial haplogroup H was associated with the improved CD4+ recovery in HIV-infected patients starting cART with CD4+ < 200 cells/mm3.
Repisalud
Publicación Artículo científico (JournalArticle)

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity

  • Pernas, Maria
  • Sanchez-Merino, Victor
  • Casado, Concepcion
  • Merino-Mansilla, Alberto
  • Olivares, Isabel
  • Yuste-Herranz, Maria Eloisa
  • Lopez-Galindez, Luis Cecilio
This study evaluated the neutralization breadth in dually infected (DI) HIV-1 long-term non-progressor elite controller patients (LTNP-EC) using a representative minipanel of 6 viruses from 5 different subtypes. Our results showed an improved neutralization breadth in DI LTNP-EC patients when compared with matched LTNP single-infected patients. The role of viral diversity in neutralization was estimated with the Shannon Entropy and the p-distance in viral quasispecies. We found a positive correlation between neutralization breadth and diversity within the viral quasispecies. This correlation could explain why a group of LTNP-EC patients developed a broad neutralizing response despite having undetectable levels of viremia.
Repisalud
Publicación Artículo científico (JournalArticle)

IL7RA rs6897932 Polymorphism is Associated with Better CD4+ T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy

  • Resino, Salvador
  • Navarrete-Muñoz, María A
  • Blanco, Julià
  • Pacheco, Yolanda María
  • Castro, Iván
  • Berenguer, Juan
  • Santos, Jesús
  • Vera-Méndez, Francisco J
  • Górgolas, Miguel
  • Jimenez-Sousa, Maria Angeles
  • Benito, José Miguel
  • Rallón, Norma
Interleukin-7 receptor subunit alpha (IL7RA) rs6897932 polymorphism is related to CD4+ recovery after combination antiretroviral therapy (cART), but no studies so far have analyzed its potential impact in patients with very low CD4+ T-cells count. We aimed to analyze the association between IL7RA rs6897932 polymorphism and CD4+ T-cells count restoration in HIV-infected patients starting combination antiretroviral therapy (cART) with CD4+ T-cells count <200 cells/mm3. We performed a retrospective study in 411 patients followed for 24 months with a DNA sample available for genotyping. The change in CD4+ T-cells count during the follow-up was considered as the primary outcome. The rs6897932 polymorphism had a minimum allele frequency (MAF) >20% and was in Hardy-Weinberg equilibrium (p = 0.550). Of 411 patients, 256 carried the CC genotype, while 155 had the CT/TT genotype. The CT/TT genotype was associated with a higher slope of CD4+ T-cells recovery (arithmetic mean ratio; AMR = 1.16; p = 0.016), higher CD4+ T-cells increase (AMR = 1.19; p = 0.004), and higher CD4+ T-cells count at the end of follow-up (AMR = 1.13; p = 0.006). Besides, rs6897932 CT/TT was related to a higher odds of having a value of CD4+ T-cells at the end of follow-up ≥500 CD4+ cells/mm3 (OR = 2.44; p = 0.006). After multiple testing correction (Benjamini-Hochberg), only the increase of ≥ 400 CD4+ cells/mm3 lost statistical significance (p = 0.052). IL7RA rs6897932 CT/TT genotype was related to a better CD4+ T-cells recovery and it could be used to improve the management of HIV-infected patients starting cART with CD4+ T-cells count <200 cells/mm3.
Repisalud
Publicación Artículo científico (JournalArticle)

Care interruptions and mortality among adults in Europe and North America

  • Trickey, Adam
  • Zhang, Lei
  • Rentsch, Christopher T
  • Pantazis, Nikos
  • Izquierdo Miguel, Rebeca
  • Antinori, Andrea
  • Leierer, Gisela
  • Burkholder, Greer
  • Cavassini, Matthias
  • Palacio-Vieira, Jorge
  • Gill, M John
  • Teira, Ramon
  • Stephan, Christoph
  • Obel, Niels
  • Vehreschild, Jörg-Janne
  • Sterling, Timothy R
  • van der Valk, Marc
  • Bonnet, Fabrice
  • Crane, Heidi M
  • Silverberg, Michael J
  • Ingle, Suzanne M
  • Sterne, Jonathan A C
  • Antiretroviral Therapy Cohort Collaboration (ART-CC)
Objective: Interruptions in care of people with HIV (PWH) on antiretroviral therapy (ART) are associated with adverse outcomes, but most studies have relied on composite outcomes. We investigated whether mortality risk following care interruptions differed from mortality risk after first starting ART. Design: Collaboration of 18 European and North American HIV observational cohort studies of adults with HIV starting ART between 2004 and 2019. Methods: Care interruptions were defined as gaps in contact of ≥365 days, with a subsequent return to care (distinct from loss to follow-up), or ≥270 days and ≥545 days in sensitivity analyses. Follow-up time was allocated to no/preinterruption or postinterruption follow-up groups. We used Cox regression to compare hazards of mortality between care interruption groups, adjusting for time-updated demographic and clinical characteristics and biomarkers upon ART initiation or re-initiation of care. Results: Of 89 197 PWH, 83.4% were male and median age at ART start was 39 years [interquartile range (IQR): 31-48)]. 8654 PWH (9.7%) had ≥1 care interruption; 10 913 episodes of follow-up following a care interruption were included. There were 6104 deaths in 536 334 person-years, a crude mortality rate of 11.4 [95% confidence interval (CI): 11.1-11.7] per 1000 person-years. The adjusted mortality hazard ratio (HR) for the postinterruption group was 1.72 (95% CI: 1.57-1.88) compared with the no/preinterruption group. Results were robust to sensitivity analyses assuming ≥270-day (HR 1.49, 95% CI: 1.40-1.60) and ≥545-day (HR 1.67, 95% CI: 1.48-1.88) interruptions. Conclusions: Mortality was higher among PWH reinitiating care following an interruption, compared with when PWH initially start ART, indicating the importance of uninterrupted care.
Repisalud
Publicación Artículo científico (JournalArticle)

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

  • Lopez-Huertas, Maria Rosa
  • Palladino, Claudia
  • Garrido-Arquero, Marta
  • Esteban-Cartelle, Beatriz
  • Sanchez-Carrillo, Marta
  • Martinez-Roman, Paula
  • Martín-Carbonero, Luz
  • Ryan, Pablo
  • Domínguez-Domínguez, Lourdes
  • de Los Santos, Ignacio
  • De La Fuente Moral, Sara
  • Benito, José Miguel
  • Rallón, Norma
  • Alcamí, José
  • Resino, Salvador
  • Fernandez-Rodriguez, Amanda
  • Coiras, Mayte
  • Briz, Veronica
In HIV-1/HCV-coinfected patients, chronic HCV infection leads to an increased T-lymphocyte immune activation compared to HIV-monoinfected patients, thereby likely contributing to increase HIV-1 reservoir that is the major barrier for its eradication. Our objective was to evaluate the influence of HCV coinfection in HIV-1 viral reservoir size in resting (r) CD4+ T-cells (CD25-CD69-HLADR-). Multicenter cross-sectional study of 97 cART-treated HIV-1 patients, including 36 patients with HIV and HCV-chronic co-infection without anti-HCV treatment, 32 HIV patients with HCV spontaneous clearance and 29 HIV-monoinfected patients. rCD4+ T-cells were isolated and total DNA was extracted. HIV viral reservoir was measured by Alu-LTR qPCR. Differences between groups were calculated with a generalized linear model. Overall, 63.9% were men, median age of 41 years and Caucasian. Median CD4+ and CD8+ T-lymphocytes were 725 and 858 cells/mm3, respectively. CD4+ T nadir cells was 305 cells/mm3. Proviral HIV-1 DNA size was significantly increased in chronic HIV/HCV-coinfected compared to HIV-monoinfected patients (206.21 ± 47.38 vs. 87.34 ± 22.46, respectively; P = 0.009), as well as in spontaneously clarified HCV co-infected patients when compared to HIV-monoinfected individuals (136.20 ± 33.20; P = 0.009). HIV-1/HCV co-infected patients showed a larger HIV-1 reservoir size in comparison to HIV-monoinfected individuals. This increase could lead to a greater complexity in the elimination of HIV-1 reservoir in HIV-1/HCV-coinfected individuals, which should be considered in the current strategies for the elimination of HIV-1 reservoir.
Repisalud
Publicación Artículo científico (JournalArticle)

Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients

  • Fernandez-Rodriguez, Amanda
  • Berenguer, Juan
  • Jimenez-Sousa, Maria Angeles
  • Garcia-Alvarez, Monica
  • Aldámiz-Echevarria, Teresa
  • Pineda-Tenor, Daniel
  • Díez, Cristina
  • De la Barrera, Jorge
  • Bellón, José María
  • Briz, Veronica
  • Resino, Salvador
Toll-like receptor 8 (TLR8) polymorphisms have been related to hepatitis C virus (HCV) infection. The aim was to estimate the association of TLR8 polymorphisms with HCV-related outcomes in HIV/HCV coinfected patients. We performed a cross-sectional study of 220 patients who underwent a liver biopsy. TLR8 polymorphisms were genotyped using GoldenGate® assay. The outcome variables were non-fibrosis (F0), mild-inflammation (A0/A1), and non-steatosis [fatty hepatocytes (FH) <10%]. Logistic regression analysis was used to compare the outcome variables according to TLR8 polymorphisms. Four polymorphisms were analyzed (rs1013151, rs5744069, rs17256081 and rs3764880rs1013151). Female patients had higher frequency of TLR8 major alleles at rs17256081 and rs101315, and minor alleles at rs3764880 and rs5744069. Male patients had higher frequency of TLR8 minor alleles except for rs3764880, where major alleles were higher (p<0.01). Two TLR8 polymorphisms (rs1013151 and rs5744069) were significantly associated with non-fibrosis (F0) [adjusted odds ratio (aOR)=4.42 (95% of confidence interval (95%CI)=1.54; 12.68) (p=0.006) and aOR=4.76 (95%CI=1.69; 13.37) (p=0.003); respectively]. When data were stratified by gender, rs1013151 and rs5744069 polymorphisms remained significant for male patients [adjusted odds ratio (aOR)=4.49 (95%CI=1.08; 18.62) (p=0.039) and aOR=6.17 (95%CI=1.45; 26.20) (p=0.014); respectively]. When data were stratified by major HCV genotypes, patients infected with HCV genotype 1 (GT1) had significant values for both rs1013151 and rs5744069 polymorphisms [aOR=5.79 (95%CI=1.44; 23.32) (p=0.013) and aOR=8.01 (95%CI=2.16; 35.65) (p=0.005); respectively]. Finally, none of the TLR8 polymorphisms were significantly associated with mild-inflammation or non-steatosis. In conclusion, TLR8 polymorphisms seem to be related to non-progression of liver fibrosis in HIV/HCV coinfected patients, particularly in males and those patients infected with GT1.
Repisalud
Publicación Artículo científico (JournalArticle)

Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.

  • Trickey, Adam
  • May, Margaret T
  • Gill, M John
  • Grabar, Sophie
  • Vehreschild, Janne
  • Wit, Ferdinand W N M
  • Bonnet, Fabrice
  • Cavassini, Matthias
  • Abgrall, Sophie
  • Berenguer, Juan
  • Wyen, Christoph
  • Reiss, Peter
  • Grabmeier-Pfistershammer, Katharina
  • Guest, Jodie L
  • Shepherd, Leah
  • Teira, Ramon
  • d'Arminio Monforte, Antonella
  • Amo, Julia del
  • Justice, Amy C
  • Costagliola, Dominique
  • Sterne, Jonathan A C
People living with HIV (PLHIV) are more likely than the general population to develop AIDS-defining malignancies (ADMs) and several non-ADMs (NADMs). Information is lacking on survival outcomes and cause-specific mortality after cancer diagnosis among PLHIV. We investigated causes of death within 5 years of cancer diagnosis in PLHIV enrolled in European and North American HIV cohorts starting antiretroviral therapy (ART) 1996-2015, aged ≥16 years, and subsequently diagnosed with cancer. Cancers were grouped: ADMs, viral NADMs and nonviral NADMs. We calculated cause-specific mortality rates (MR) after diagnosis of specific cancers and compared 5-year survival with the UK and France general populations. Among 83,856 PLHIV there were 4,436 cancer diagnoses. Of 603 deaths after ADM diagnosis, 292 (48%) were due to an ADM. There were 467/847 (55%) and 74/189 (39%) deaths that were due to an NADM after nonviral and viral NADM diagnoses, respectively. MR were higher for diagnoses between 1996 and 2005 versus 2006-2015: ADMs 102 (95% CI 92-113) per 1,000 years versus 88 (78-100), viral NADMs 134 (106-169) versus 111 (93-133) and nonviral NADMs 264 (232-300) versus 226 (206-248). Estimated 5-year survival for PLHIV diagnosed with liver (29% [19-39%]), lung (18% [13-23%]) and cervical (75% [63-84%]) cancer was similar to general populations. Survival after Hodgkin's lymphoma diagnosis was lower in PLHIV (75% [67-81%]). Among ART-treated PLHIV diagnosed with cancer, MR and causes of death varied by cancer type, with mortality highest for liver and lung cancers. Deaths within 5 years of NADM diagnoses were more likely to be from cancer than AIDS.
Repisalud
Publicación Artículo científico (JournalArticle)

Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

  • Ruiz-de-León, María J
  • Jimenez-Sousa, Maria Angeles
  • Moreno, Santiago
  • García, Marcial
  • Gutiirrez-Rivas, Monica
  • León, Agathe
  • Montero-Alonso, Marta
  • González-García, Juan
  • Resino, Salvador
  • Rallón, Norma
  • Benito, José Miguel
  • Vallejo, Alejandro
  • ECRIS Network integrated in the Spanish AIDS Research Network
  • Briz, Veronica
  • Vázquez-Morón, Sonia
  • Fernández, A
  • García, P
  • Pernas, Maria
  • Casado, Concepcion
  • López, C
  • Capa, Laura
  • Pérez, M
  • Alcamí, José
Exosome-derived miR-21 was independently associated with CD4 T cell decline in HIV-1-infected elite controllers (OR 0.369, 95% CI 0.137-0.994, p = 0.049). Also, a negative correlation between miR-21 expression and MCP-1 level was found (r = -0.649, p = 0.020), while no correlation between soluble biomarkers or cellular immune activation was found.
Repisalud
Publicación Artículo científico (JournalArticle)

Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression

  • Restrepo, Clara
  • Gutiirrez-Rivas, Monica
  • Pacheco, Yolanda María
  • García, Marcial
  • Blanco, Julià
  • Medrano, Luz Maria
  • Navarrete-Muñoz, María A
  • Gutiérrez, Félix
  • Miralles, Pilar
  • Dalmau, David
  • Gómez, Juan Luis
  • Górgolas, Miguel
  • Cabello, Alfonso
  • Resino, Salvador
  • Benito, José Miguel
  • Rallón, Norma
OBJECTIVE: We investigated the association of genetic polymorphisms in chemokine and chemokine receptor genes with poor immunological recovery in HIV patients starting combined antiretroviral therapy (cART) with low CD4 T-cell counts. METHODS: A case-control study was conducted in 412 HIV-infected patients starting cART with CD4 T-cell count <200 cells/μL and successful viral control for two years. CD4 count increase below 200 cells/μL after two years on cART was used to define INR (immunological non-responder) patients. Polymorphisms in CXCL12, CCL5 and CCR2 genes were genotyped using sequenom's MassARRAY platform. RESULTS: Thirty two percent (134/412) of patients were classified as INR. After adjusting by age, route of HIV infection, length of infection before cART and viral hepatitis coinfection, CCR2 rs1799864-AG genotype was significantly associated with INR status (OR [95% CI]: 1.80 [1.04-3.11]; p = 0.04), and CXCL12 rs1801157-TT genotype showed a trend (OR [95% CI]: 2.47 [0.96-6.35]; p = 0.06). CONCLUSIONS: CCR2 rs1799864-AG or CXCL12 rs1801157-TT genotypes influence on the probability of poor CD4 recovery in the population of HIV patients starting cART with low CD4 counts. Genotyping of these polymorphisms could be used to estimate the risk of poor CD4 restoration, mainly in patients who are diagnosed late in the course of infection.
Repisalud
Publicación Artículo científico (JournalArticle)

Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy

  • Morales-Molina, Alvaro
  • Rodriguez-Milla, Miguel A
  • García-Rodriguez, Patricia
  • Hidalgo, Laura
  • Alemany, Ramon
  • Garcia-Castro, Javier
Oncolytic viruses often face challenges in achieving optimal antitumor immunity as standalone therapies. The penton base RGD-integrin interactions play a significant role in wild-type adenovirus-induced innate immune responses. To modify these responses, we present ISC301, a novel oncolytic adenovirus engineered by deleting the natural RGD motifs in the penton base while incorporating artificial RGD motifs in the fiber knobs. ISC301 demonstrated comparable infectivity, cytotoxic effects, and signaling profiles across various cell types to its parental ICOVIR-5, which retains the penton base RGD motif. In immunodeficient and immunocompetent mouse models, ISC301 exhibited similar antitumor efficacy to ICOVIR-5. However, ISC301 induced higher intratumoral inflammation through NF-κB activation, leading to increased levels of tumor-infiltrating leukocytes and higher proportion of cytotoxic CD8 T cells. In addition, ISC301 elicits a heightened pro-inflammatory response in peripheral blood. Importantly, when combined with CAR T cell therapy, ISC301 exhibited superior antitumor efficacy, surpassing monotherapy outcomes. These findings emphasize the impact of adenoviral modifications on antitumor immune responses. The deletion of penton base RGD motifs enhances ISC301's pro-inflammatory profile and boosts CAR T cell therapy efficacy. This study enhances understanding of oncolytic virus engineering strategies, positioning ISC301 as a promising candidate for combined immunotherapeutic approaches in cancer treatment.
Repisalud
Publicación Artículo científico (JournalArticle)

Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study

  • Garcia-Alvarez, Monica
  • Berenguer, Juan
  • Jimenez-Sousa, Maria Angeles
  • Pineda-Tenor, Daniel
  • Aldámiz-Echevarria, Teresa
  • Tejerina, Francisco
  • Díez, Cristina
  • Vázquez-Morón, Sonia
  • Resino, Salvador
The mechanisms involved in the chronic hepatitis C progression are incompletely understood. The aim was to analyze the association between 2'5'oligoadenylate synthetase 1,2 and 3 (OAS1-3) and myxovirus resistance proteins 1 (Mx1) polymorphisms and severity of liver disease in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients. We performed a cross-sectional study in 219 patients that underwent a liver biopsy. DNA genotyping for Mx1 (rs469390), OAS1 (rs2285934), OAS2 (rs1293762) and OAS3 (rs2010604) was performed by using GoldenGate assay. The outcome variables ion liver biopsy were: (i) significant fibrosis (F ≥ 2); (ii) moderate activity grade (A ≥ 2). Additive model of inheritance for genetic association test was used. The likelihood of having significant fibrosis (F ≥ 2) was lower in patients carrying OAS2 rs1293762 A allele [adjusted odds ratio (aOR) = 0.51; p = 0.040]. Besides, the likelihood of having moderate activity grade (A ≥ 2) was higher in patients carrying Mx1 rs464397 C allele (aOR = 1.63; p = 0.028) and Mx1 rs469390 G allele (aOR = 1.97; p = 0.005), while it was lower in patients carrying OAS1 rs2285934 A allele (aOR = 0.64; p = 0.039) and OAS2 rs1293762 A allele (aOR = 0.41; p = 0.009). In conclusion, Mx1 and OAS1-2 polymorphisms were associated with the severity of liver disease in HIV/HCV-coinfected patients, suggesting a significant role in the progression of hepatic fibrosis.
Repisalud
Publicación Artículo científico (JournalArticle)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

  • Casado, Concepcion
  • Gálvez, Cristina
  • Pernas, Maria
  • Tarancon-Diez, Laura
  • Rodriguez, Carmen
  • Sanchez-Merino, Victor
  • Vera, Mar
  • Olivares, Isabel
  • De Pablo-Bernal, Rebeca
  • Merino-Mansilla, Alberto
  • Del Romero, Jorge
  • Lorenzo-Redondo, Ramon
  • Ruiz-Mateos, Ezequiel
  • Salgado, María
  • Martinez-Picado, Javier
  • Lopez-Galindez, Luis Cecilio
Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control viral replication. However, natural virological suppression and absence of immune dysfunction are not always long-term sustained. We define exceptional EC (EEC) as HIV-1 subjects who maintain the EC characteristics without disease progression for more than 25 years. We analyzed three EEC, diagnosed between 1988 and 1992, who never showed signs of clinical disease progression in absence of any antiretroviral treatment. A comprehensive clinical, virological, and immunological study was performed. The individuals simultaneously exhibited ≥3 described host protective alleles, low levels of total HIV-1 DNA (<20 copies/106 CD4+ T-cells) without evidence of replication-competent viruses (<0.025 IUPM), consistent with high levels of defective genomes, strong cellular HIV-1-specific immune response, and a high poly-functionality index (>0.50). Inflammation levels of EEC were similar to HIV-1 negative donors. Remarkably, they showed an exceptional lack of viral evolution and 8-fold lower genetic diversity (<0.01 s/n) in env gene than other EC. We postulate that these EEC represent cases of spontaneous functional HIV-1 cure. A non-functional and non-genetically evolving viral reservoir along with an HIV-1-specific immune response seems to be key for the spontaneous functional cure.
Repisalud
Publicación Artículo científico (JournalArticle)

HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic

  • Cabrera-Rodríguez, Romina
  • Hebmann, Veronique
  • Marfil, Silvia
  • Pernas, Maria
  • Marrero-Hernández, Sara
  • Cabrera, Cecilia
  • Urrea, Víctor
  • Casado, Concepcion
  • Olivares, Isabel
  • Márquez-Arce, Daniel
  • Pérez-Yanes, Silvia
  • Estévez-Herrera, Judith
  • Clotet, Bonaventura
  • Espert, Lucile
  • Lopez-Galindez, Luis Cecilio
  • Biard-Piechaczyk, Martine
  • Valenzuela-Fernández, Agustín
  • Blanco, Julià
In untreated HIV-1-infected individuals, viremia is positively associated with disease progression. However, some viremic non progressors (VNPs) individuals show paradoxical high CD4+ T cell counts. HIV-1 envelope glycoprotein complex (Env) is a major cytopathic determinant in viral replication; therefore, we have deeply characterized Env function in this rare clinical phenotype. Full-length Env clones isolated from individuals with Viral Load (VL) > 10,000 copies/mL classified as VNPs (n = 15) or rapid progressors (RPs, n = 17) were geno- and phenotypically analyzed by determining diversity, expression, CD4 binding/signaling, fusogenicity, infectivity and autophagy induction. Selected Env clones from VNPs and RPs (n = 32) showed similar expression, fusion and infection abilities. Env clones from both groups showed similar affinity for CD4 during cell-to-cell transmission and consistently induced similar levels of CD4 signaling, measured by α-tubulin acetylation. Moreover, we demonstrate for the first time that primary Env clones from VNP and RP induce autophagy in uninfected cells and that this feature correlated with fusogenic capacity but was unrelated to disease progression. In conclusion, our data suggest that Env clones from VNP individuals are fully functional. Therefore, the paradoxical CD4+ T cell count stability coexisting with high levels of viral replication is unrelated to Env function.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Assessing the Sustainability of High-Value Brands in the IT Sector

  • Alcaide González, María Ángeles
  • De la Poza, Elena|||0000-0003-2303-0811
  • Guadalajara Olmeda, María Natividad|||0000-0002-5992-3446
[EN] Nowadays, companies have more freedom on how they can report their corporate social responsibility (CSR) actions and outcomes, despite them being increasingly important for how investors and shareholders can obtain knowledge about companies¿ non-financial aspects. This is why more importance is being attached to sustainability rankings as an additional tool to seek excellence and distinguish between companies. The main objective of the present research was to analyze the degree of similarity in sustainability valuations among the most important open-access sustainability rankings that have appeared in the last decade (Green Ranking, RepTrack, Global 100 most sustainable corporations, and Finance Yahoo Sustainability). The secondary objective was to study whether these rankings incorporated the most de facto prestigious brands, and the third objective was to learn of the influence of the level of controversy in Finance Yahoo Sustainability scores in technological companies. Our results reveal wide variability among open-access CSR rankings. Not all the most valued brands appear in the sustainability rankings, which indicates the differences between the rankings of brands and CSR rankings. Finally, the level of controversy was found to be an important aspect in companies¿ CSR scores.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure

  • Mollar, Anna
  • Garcia-Conejo, Celia
  • Revuelta-Lopez, Elena
  • Cardells, Ingrid
  • Lopez, Raquel
  • Canto Serrano, Irene Del
  • de la Espriella, Rafael
  • Lopez-Lereu, Maria P.
  • Monmeneu, Jose Vicente
  • Maceira, Alicia
  • Lakhal-Littleton, Samira
  • Almenar, Luis
  • Cases, Aleix
  • Peiro, Marta
  • Bayes Genis, Antonio
[EN] Iron deficiency (ID) treated with ferric carboxymaltose (FCM) previously showed reduced platelet count; however, no studies have evaluated its biological significance in heart failure. In the current study, we aimed to: (a) assess the changes in platelet count at 7 and 30 days post-FCM, and (b) explore its association with non-invasive surrogates of myocardial iron uptake and left systolic function in patients with ID and heart failure with left ventricular ejection fraction < 50% (HFrEF and HFmrEF). This post-hoc analysis of a randomized, double-blind, FCM vs. placebo clinical trial (Myocardial-IRON Trail) involved 45 outpatients with HFrEF and HFmrEF and ID in which the platelet count value was available. Platelet count, cardiac magnetic resonance T1-mapping and 3D-global longitudinal strain (CMR-GLS) were assessed at baseline, 7, and 30 days. Linear regression models were used to evaluate the between-treatment differences and endpoints. The mean (SD) age was 71 +/- 8 years, and 32 (71%) were men. At 30 days, we found a significant reduction in platelet count in those treated with FCM (p-value = 0.027). In those treated with FCM, the greater 30-day decrease in platelets showed lower 30-day changes in T1-mapping (p = 0.024) and CMR-GLS (p = 0.028). After administration of FCM, we found a significant 30-day reduction in platelet count. The greater platelet count reduction was related to lower myocardial iron repletion and a smaller improvement in left ventricular systolic function., This work was supported in part by an unrestricted grant from Vifor Pharma, CIBER Cardiovascular [grant numbers 16/11/00420 and 16/11/00403], Unidad de Investigacion Clinica y Ensayos Clinicos INCLIVA Health Research Institute, Spanish Clinical Research Network (SCReN; PT13/0002/0031 and PT17/0017/0003), cofounded by Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III, and Proyectos de Investigacion de la Seccion de Insuficiencia Cardiaca 2017 from the Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment

  • Parés, Marta
  • Pallaruelo-Santamaría, Víctor
  • Fillat, Cristina
  • Martínez-Latorre, Javier|||0000-0001-5421-5371
  • Candela-Noguera, Vicente
  • Soriano-Teruel, Paula
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and treatment-resistant malignancies, with limited efficacy to conventional treatments such as surgical resection or chemotherapy. This clinical scenario underscores the need for novel therapeutic strategies. The development of multifunctional platforms capable of targeting tumors through multiple mechanisms offers an innovative strategy to overcome this challenge. Lipid nanoparticles (LNPs) offer a versatile platform capable of efficiently delivering genetic material. Moreover, through surface functionalization it is feasible to improve LNP performance optimizing therapeutic outcomes in a single formulation. Here, we explored a dual functionalization strategy of the LNP for tumor targeting and tumor remodeling to improve treatment efficacy. LNPs were designed for delivering reporter DNA plasmid or mRNA into the PDAC cellular models Capan-2 and PANC-1. The DNA plasmid contains a pancreatic cancer-specific chimeric promoter for transcriptional specificity to PDAC cells. Besides, LNPs were functionalized with folate and an anti-CD47 antibody to both target the folate receptor in PDAC cells and block CD47-mediated immune evasion. Both pDNA and mRNA LNPs targeted PDAC cells in a dose-dependent manner, with mRNA-LNPs demonstrating more efficient transfection. Notably, LNPs functionalized with the anti-CD47 antibody increased phagocytosis in vitro, and promoted an inflammatory phenotype of M1-like macrophages in mouse Capan-2 xenografts. This combinatorial design of the formulated LNP represents an innovative therapeutic strategy and opens future perspectives in the search for effective treatments for PDAC. Keywords: Lipid nanoparticles; Immunotherapy; ACD47; Folate; Macrophages; Pancreatic cancer, This research was supported by European Union s Horizon 2020 research and innovation programme under grant agreement No 899708 (ULISES). The work has also received funding from projects PID2020- 119692RB-C22, PID2023-146637OB-C22, PID2021-128141OBC22, PID2021-126304OB-C41 and PID2024-155683OB-C41 funded by MCIN-Ministerio de Ciencia e Innovacion ¿ and by the European Regional Development Fund A way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012) and (RD21/0017/0012) Instituto de Salud Carlos III, the Generalitat de Catalunya (SGR21/01169). The research leading to these results has also received funding from la Caixa Foundation under agreement LCF/PR/ SP23/52950009. The Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.M-L. is grateful to the Spanish MECD for his FPU grant (FPU19/06219). PM.S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). We also acknowledge the support of CERCA Programme/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Kinematics of Big Biomedical Data to characterize temporal variability and seasonality of data repositories: Functional Data Analysis of data temporal evolution over non-parametric statistical manifolds

  • Sáez, Carlos
  • Garcia-Gomez, Juan M
[EN] Aim: The increasing availability of Big Biomedical Data is leading to large research data samples collected over long periods of time. We propose the analysis of the kinematics of data probability distributions over time towards the characterization of data temporal variability. Methods: First, we propose a kinematic model based on the estimation of a continuous data temporal trajectory, using Functional Data Analysis over the embedding of a non-parametric statistical manifold which points represent data temporal batches, the Information Geometric Temporal (IGT) plot. This model allows measuring the velocity and acceleration of data changes. Next, we propose a coordinate-free method to characterize the oriented seasonality of data based on the parallelism of lagged velocity vectors of the data trajectory throughout the IGT space, the Auto-Parallelism of Velocity Vectors (APVV) and APVVmap. Finally, we automatically explain the maximum variance components of the IGT space coordinates by means of correlating data points with known temporal factors from the domain application. Materials: Methods are evaluated on the US National Hospital Discharge Survey open dataset, consisting of 3,25M hospital discharges between 2000 and 2010. Results: Seasonal and abrupt behaviours were present on the estimated multivariate and univariate data trajectories. The kinematic analysis revealed seasonal effects and punctual increments in data celerity, the latter mainly related to abrupt changes in coding. The APVV and APVVmap revealed oriented seasonal changes on data trajectories. For most variables, their distributions tended to change to the same direction at a 12-month period, with a peak of change of directionality at mid and end of the year. Diagnosis and Procedure codes also included a 9-month periodic component. Kinematics and APVV methods were able to detect seasonal effects on extreme temporal subgrouped data, such as in Procedure code, where Fourier and autocorrelation methods were not able to. The automated explanation of IGT space coordinates was consistent with the results provided by the kinematic and seasonal analysis. Coordinates received different meanings according to the trajectory trend, seasonality and abrupt changes. Discussion: Treating data as a particle moving over time through a multidimensional probabilistic space and studying the kinematics of its trajectory has turned out to a new temporal variability methodology. Its results on the NHDS were aligned with the dataset and population descriptions found in the literature, contributing with a novel temporal variability characterization. We have demonstrated that the APVV and APVVmat are an appropriate tool for the coordinate-free and oriented analysis of trajectories or complex multivariate signals. Conclusion: The proposed methods comprise an exploratory methodology for the characterization of data temporal variability, what may be useful for a reliable reuse of Big Biomedical Data repositories acquired over long periods of time., This work was supported by UPV grant No. PAID-00-17, and projects DPI2016-80054-R and H2020-SC1-2016-CNECT No. 727560.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

EHRtemporalVariability: delineating temporal data-set shifts in electronic health records

  • Sáez Silvestre, Carlos|||0000-0003-2678-8249
  • Garcia-Gomez, Juan M
  • Gutiérrez-Sacristán, Alba
  • Kohane, Isaac
  • Avillach, Paul
[EN] Background: Temporal variability in health-care processes or protocols is intrinsic to medicine. Such variability can potentially introduce dataset shifts, a data quality issue when reusing electronic health records (EHRs) for secondary purposes. Temporal data-set shifts can present as trends, as well as abrupt or seasonal changes in the statistical distributions of data over time. The latter are particularly complicated to address in multimodal and highly coded data. These changes, if not delineated, can harm population and data-driven research, such as machine learning. Given that biomedical research repositories are increasingly being populated with large sets of historical data from EHRs, there is a need for specific software methods to help delineate temporal data-set shifts to ensure reliable data reuse. Results: EHRtemporalVariability is an open-source R package and Shiny app designed to explore and identify temporal data-set shifts. EHRtemporalVariability estimates the statistical distributions of coded and numerical data over time; projects their temporal evolution through non-parametric information geometric temporal plots; and enables the exploration of changes in variables through data temporal heat maps. We demonstrate the capability of EHRtemporalVariability to delineate data-set shifts in three impact case studies, one of which is available for reproducibility. Conclusions: EHRtemporalVariability enables the exploration and identification of data-set shifts, contributing to the broad examination and repurposing of large, longitudinal data sets. Our goal is to help ensure reliable data reuse for a wide range of biomedical data users. EHRtemporalVariability is designed for technical users who are programmatically utilizing the R package, as well as users who are not familiar with programming via the Shiny user interface., This work was supported by Universitat Politecnica de Valencia grant PAID-00-17, Generalitat Valenciana grant BEST/2018, and projects H2020-SC1-2016-CNECT No. 727560 and H2020-SC1-BHC-2018-2020 No. 825750
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Is the sustainability profile of FinTech companies a key driver of their value?

  • Merello Giménez, Paloma
  • Barbera, Antonio
  • De la Poza, Elena|||0000-0003-2303-0811
[EN] The digitisation process is affecting all markets and raising consumer awareness about companies' sustainable behaviour. This work studies the effect of the sustainability profile of FinTech companies on the firm (market value and book value) as the factors that add value to investors and motivate their evolution in markets are still unknown. Using the KBW and Nasdaq FinTech Indices, and the NASDAQ Insurance Index (IXIS), we composed a panel of 95 companies over a 10-year period (2010-2019) with economic-financial variables and data about green certificates and sustainability indices. The applied methodology is based on dynamic (GMM-SYS) and static (PCSE) panel data models. Our results show that the market value of FinTech companies is positively driven by an CSR report being issued, the position in the CSR RepTrak, company size and board size. In contrast, the number of green certificates, particularly their position in the Green Ranking, is negatively related to their market value. Surprisingly in the most transparent companies, the direction of the variables effect evidenced for the book value per share is the opposite to market capitalisation., this work has been partially supported by the Spanish Ministry of Science and Innovation under the research project PID2020-117792RA-I00
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A novel synthetic approach to tyrosine dimers based on pterin photosensitization

  • Reid, Lara O.
  • Castaño, Carolina
  • Dantola, M L.
  • Miranda Alonso, Miguel Ángel
  • Thomas, A. H.
  • Lhiaubet, Virginie Lyria|||0000-0002-8205-8892
  • Marín García, Mª Luisa|||0000-0002-9789-8894
[EN] Oxidative damage to proteins leads to a variety of modifications that are markers of pathogenesis. One of the most important modifications is the dityrosine (Tyr(2)) cross-link, resulting from an oxidative covalent bond between two tyrosines (Tyr). An optimized methodology for preparation of pure Tyr(2) is important to investigate in detail its physicochemical properties and reactivity. Pterin (Ptr), the parent and unsubstituted compound of oxidized pterins, is able to photosensitize the cross-linking of free tyrosine (Tyr) and tyrosine residues of peptides and proteins through a photoinduced electron transfer mechanism. We have optimized a simple, one-step photocatalyzed formation of Tyr(2), using Ptr as photocatalyst. Our procedure is carried out in aqueous solutions under UV-A radiation for few minutes. The purification of Tyr(2) is performed by reverse-phase chromatography. The obtained highly pure solution is used to fully characterize the Tyr(2) (exact mass and H-1, H-1-H-1 COSY; DEPT; HSQC and HMBC NMR experiments) and to deeper study its fluorescence properties. (C) 2017 Elsevier Ltd. All rights reserved., The present work was partially supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; Grant PIP 0304), Agencia de Promocion Cientifica y Tecnologica (ANPCyT; Grants PICT 2012-0508), and Universidad Nacional de La Plata (UNLP; Grant X586 and X712). L.O.R. and C.C. thanks CONICET for doctoral research fellowships. Funding from the Programa CSIC de Cooperacion Cientifica para el Desarrollo (iCOOPLight project ref 20105CD0017) is gratefully acknowledged. A.H.T. and M.L.D are research members of CONICET. The authors thank Dr. Mariana Vignoni (INIFTA, CONICET) and Nathalie Martins-Froment of the Service Commun de Spectrometrie de Masse (FR2599), Universite de Toulouse III (Paul Sabatier) for their crucial contributions in mass spectrometry measurements.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Sustainability of quality of life investments based on the digital transformation

  • Barykin, Sergey
  • Sergeev, Sergey
  • Kapustina, Irina
  • Borisoglebskaya, Larisa
  • Varlamova, Daria
  • Ovakimyan, Marianna
  • Karmanova, Anna
  • De la Poza, Elena|||0000-0003-2303-0811
[EN] : In this paper, the problem of sustainability of investment activity in the direction of the high yield investment program is considered. In these financial instruments, large amounts of money are accumulated, consisting of contributions from the vast majority of the population. For example, pension funds inherent in most developed countries, insurance institutions, etc., can be indicated. Accordingly, the social significance of their activities and the impact on the quality of life of all segments of the population increase, The research was partially funded by the Ministry of Science and Higher Ed-ucation of the Russian Federation under the strategic academic leadership program 'Priority 2030' (Agreement 075-15-2021-1333 dated 30.09.2021).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Toward a common approach for assessing the conservation status of marine turtle species within the European marine strategy framework directive

  • Girard, Fanny
  • Girard, Alexandre
  • Monsinjon, Jonathan
  • Arcangeli, Antonella
  • Cardona, Luis
  • Casale, Paolo
  • Catteau, Sidonie
  • David, Léa
  • Dell Amico, Florence
  • Gambaiani, Delphine
  • Girondot, Marc
  • Jribi, Imed
  • Lauriano, Giancarlo
  • Luschi, Paolo
  • Belda, EJ|||0000-0003-1995-1271
[EN] Environmental policies, including the European Marine Strategy Framework Directive (MSFD), generally rely on the measurement of indicators to assess the good environmental status (GES) and ensure the protection of marine ecosystems. However, depending on available scientific knowledge and monitoring programs in place, quantitative GES assessments are not always feasible. This is specifically the case for marine turtle species, which are listed under the Biodiversity Descriptor of the MSFD. Relying on an expert consultation, the goal of this study was to develop indicators and a common assessment approach to be employed by European Union Member States to evaluate the status of marine turtle populations in the frame of the MSFD. A dedicated international expert group was created to explore and test potential assessment approaches, in coherence with other environmental policies (i.e. Habitats Directive, OSPAR and Barcelona Conventions). Following a series of workshops, the group provided recommendations for the GES assessment of marine turtles. In particular, indicators and assessment methods were defined, setting a solid basis for future MSFD assessments. Although knowledge gaps remain, data requirements identified in this study will guide future data collection initiatives and inform monitoring programs implemented by EU Member States. Overall this study highlights the value of international collaboration for the conservation of vulnerable species, such as marine turtles., This study was funded by the French Ministry of Environment (MTES-MNHN Conventions n degrees 2102636187 (2019) and n degrees 2102994526 (2020)). DM acknowledges support from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement n degrees 794938. The work of ADM was supported by the Hellenic Foundation for Research and Innovation (H.F.R.I.) under the "First Call for H.F.R.I. Research Projects to support Faculty members and Researchers and the procurement of high-cost research equipment grant" (Project Number: 2340). FV was supported by the Investigator Programme of the Fundacao para a Ciencia e Tecnologia (FCT, CEECIND/03469/2017, CEECIND/03426/2020).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Seasonal Local Models for Glucose Prediction in Type 1 Diabetes

  • Montaser, Eslam
  • Rossetti, Paolo
  • Rashid, Mudassir
  • Cinar, Ali
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Linear empirical dynamic models have been widely used for blood glucose prediction and risks prevention in people with type 1 diabetes. More accurate blood glucose prediction models with longer prediction horizon (PH) are desirable to enable warnings to patients about imminent blood glucose changes with enough time to take corrective actions. In this study, a blood glucose prediction method is developed by integrating the predictions of a set of seasonal local models (each of them corresponding to different glucose profiles observed along historical data). In the modeling step, the number of sets and their corresponding glucose profiles characteristics are obtained by clustering techniques (Fuzzy C-Means). Then, Box-Jenkins methodology is used to identify a seasonal model for each set. Finally, blood glucose predictions of local models are integrated using different techniques. The proposed method is tested by using 18 60-h closed-loop experiments (including different exercise types and artificial pancreas strategies) and achieving mean absolute percentage error (MAPE) of 2.94%, 3.89%, 5.41%, 6.29% and 8.66% for 15-, 30-, 45-, 60-, and 90-min PHs, respectively., This work was supported in part by the Spanish Ministry of Economy and Competitiveness under Grants DPI2016-78831-C2-1-R, BES-2014-069253 and EEBB-I-17-12320, in part by the European Union through FEDER funds, and in part Universitat Politecnica de Valencia PAID-00-17 Program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Sustainability of Management Decisions in a Digital Logistics Network

  • Barykin, Sergey Evgenievich
  • Borisoglebskaya, Larisa Nikolaevna
  • Provotorov, Vyacheslav Vasilyevich
  • Kapustina, Irina Vasilievna
  • Sergeev, Sergey Mikhailovich
  • Saychenko, Lilya
  • De la Poza, Elena|||0000-0003-2303-0811
[EN] Globalization has given a powerful impetus to the development of international commercial activity and logistics management systems taking full advantage of cross-border networking. The solution lies at the intersection of information technologies, technical means of machine-to-machine (M2M) interaction, mobile high-speed networks, geolocation, cloud services, and a number of international standards. The current trend towards creating digital logistics platforms has set a number of serious challenges for developers. The most important requirement is the condition of sustainability of the obtained solutions with respect to disturbances in the conditions of logistics activities caused not only by market uncertainty but also by a whole set of unfavorable factors accompanying the transportation process. Within the framework of the presented research, the problem of obtaining the conditions for the stability of solutions obtained on the basis of mathematical models is set. At the same time, the processes of transferring not only discrete but also continuous material flows through complex structured networks are taken into account. This study contains the results of the analysis of the stability of solutions of differential systems of various types that simulate the transfer processes in network media. Initial boundary value problems for evolutionary equations and differential-difference systems are relevant in logistics, both for the discrete transportation of a wide range of goods and for the quasi-continuous transportation of, for example, liquid hydrocarbons. The criterion for the work of a logistics operator is the integral functional. For the mathematical description of the transport process of continuous and discrete media, a wide class of integrable functions are used, which adequately describe the transport of media with a complex internal rheological structure., The reported study was funded by RFBR according to the research projet No 20-014-00029.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Vascular Senescence: A Potential Bridge Between Physiological Aging and Neurogenic Decline

  • Rojas-Vázquez, Sara
  • Blasco-Chamarro, Laura
  • López-Fabuel, Irene
  • Fariñas, Isabel
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The adult mammalian brain contains distinct neurogenic niches harboring populations of neural stem cells (NSCs) with the capacity to sustain the generation of specific subtypes of neurons during the lifetime. However, their ability to produce new progeny declines with age. The microenvironment of these specialized niches provides multiple cellular and molecular signals that condition NSC behavior and potential. Among the different niche components, vasculature has gained increasing interest over the years due to its undeniable role in NSC regulation and its therapeutic potential for neurogenesis enhancement. NSCs are uniquely positioned to receive both locally secreted factors and adhesion-mediated signals derived from vascular elements. Furthermore, studies of parabiosis indicate that NSCs are also exposed to blood-borne factors, sensing and responding to the systemic circulation. Both structural and functional alterations occur in vasculature with age at the cellular level that can affect the proper extrinsic regulation of NSCs. Additionally, blood exchange experiments in heterochronic parabionts have revealed that age-associated changes in blood composition also contribute to adult neurogenesis impairment in the elderly. Although the mechanisms of vascular- or blood-derived signaling in aging are still not fully understood, a general feature of organismal aging is the accumulation of senescent cells, which act as sources of inflammatory and other detrimental signals that can negatively impact on neighboring cells. This review focuses on the interactions between vascular senescence, circulating pro-senescence factors and the decrease in NSC potential during aging. Understanding the mechanisms of NSC dynamics in the aging brain could lead to new therapeutic approaches, potentially include senolysis, to target age-dependent brain decline., Work in the laboratory of IF is supported by Spanish grants from FEDER/Ministerio de Ciencia e Innovación (MICI)-Agencia Estatal de Investigación (SAF2017-86690-Rand Network of Excellence iDIFFER RED2018-102723-T), Instituto de Salud Carlos III (CIBERNED CB06/05/0086 and RETIC Tercel RD16/0011/0017) and Generalitat Valenciana (Prometeo 2017/030). Work in the laboratory of RM-M is supported by Spanish Government project RTI2018-100910-B-C41 (MCUI/FEDER, EU) and the Generalitat Valenciana project PROMETEO 2018/024. SR-V and LB-C are recipients of predoctoral contracts from the Spanish Ministerio de Educación. IL-F is a recipient of a Juan de la Cierva postdoctoral contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Time-Driven Data Placement Strategy for a Scientific Workflow Combining Edge Computing and Cloud Computing

  • Lin, Bing
  • Zhu, Fangning
  • Zhang, Jianshan
  • Chen, Jiaqing
  • Chen, Xing
  • Xiong, Naixue N.
  • Lloret, Jaime|||0000-0002-0862-0533
[EN] Compared to traditional distributed computing environments such as grids, cloud computing provides a more cost-effectiveway to deploy scientificworkflows. Each task of a scientific workflow requires several large datasets that are located in different datacenters, resulting in serious data transmission delays. Edge computing reduces the data transmission delays and supports the fixed storing manner for scientific workflow private datasets, but there is a bottleneck in its storage capacity. It is a challenge to combine the advantages of both edge computing and cloud computing to rationalize the data placement of scientific workflow, and optimize the data transmission time across different datacenters. In this study, a self-adaptive discrete particle swarm optimization algorithm with genetic algorithm operators (GA-DPSO) was proposed to optimize the data transmission time when placing data for a scientific workflow. This approach considered the characteristics of data placement combining edge computing and cloud computing. In addition, it considered the factors impacting transmission delay, such as the bandwidth between datacenters, the number of edge datacenters, and the storage capacity of edge datacenters. The crossover and mutation operators of the genetic algorithm were adopted to avoid the premature convergence of traditional particle swarm optimization algo-rithm, which enhanced the diversity of population evolution and effectively reduced the data transmission time. The experimental results show that the data placement strategy based on GA-DPSO can effectively reduce the data transmission time during workflow execution combining edge computing and cloud computing., This work was supported in part by the National Key R&D Program of China under Grant 2018YFB1004800, in part by the Natural Science Foundation of Fujian Province under Grant 2019J01061386, in part by the Guiding Project of Fujian Province under Grant 2018H0017, in part by the Talent Program of Fujian Province for Distinguished Young Scholars in Higher Education, and in part by the Electronic Information and Control Open Fund of Fujian University Engineering Research Center under Grant MJXY-KF-EIC1802. Paper no. TII-19-0313. (Corresponding author: Xing Chen.)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Study of the transport properties of the mixed ionic electronic conductor Ce 1-x Tb x O 2- + Co (x=0.1, 0.2) and evaluation as oxygen-transport membrane

  • Balaguer Ramirez, Maria|||0000-0002-7098-9235
  • Serra Alfaro, José Manuel|||0000-0002-1515-1106
  • Solis Díaz, Cecilia
[EN] Tb-doped ceria materials have been synthesized by the coprecipitation method. Cobalt oxide (2 mol %) has been added in order to improve the sinterability and conductivity. XRD measurements suggest that a part of the cobalt is incorporated in the ceria lattice. Ce1¿xTbxO2¿¿ materials showed predominantly ionic conductivity, but the mixed ionic electronic conductivity can be tuned by modifying Tb and Co doping level and temperature range. The ambipolar conductivity was determined by galvanic method coupled with gas permeation and these results support the applicability of these materials as oxygen transport membranes at high temperature. Ce1¿xTbxO2¿¿ +Co membranes are CO2 stable and yielded oxygen fluxes that can compete with reported perovskite materials. Oxygen diffusion and surface exchange coefficients in the range 1 ¿ 10¿5 to 1 ¿ 10¿4 cm2/s and 1 ¿ 10¿4 to 1 ¿ 10¿3 cm/s from 773 to 1023 K have been obtained by conductivity relaxation., Financial support by the Spanish Ministry for Science and Innovation (Project ENE2008-06302, Grant JAE-Pre 08-0058, and Grant BES-2009-015835), Spanish Industry Ministry (Project IAP-560620-2008-17), the EU through FP7 NASA-OTM Project (NMP3-SL-2009-228701) and Instalaciones Inabensa S.A. is kindly acknowledged. The help of Dr. Jorda (HT-XRD) is kindly acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Modelling it brand values supplied by consultancy service companies: empirical evidence for differences

  • Alcaide González, María Ángeles
  • Guadalajara Olmeda, María Natividad|||0000-0002-5992-3446
  • De la Poza, Elena|||0000-0003-2303-0811
[EN] Brands are the most precious intangible companies' assets. Company managers need to know their brand value and the aspects determining it. As no transparent brands market exists, the main objective of this study was to model brand values that the world's main valuation consultants publish. The obtained results indicate that 80% of the value of these brands is accounted for by both the net results of the companies that own brands and their value on the Stock Exchange. These results allow brand values to be estimated using quantitative and objective information by simple methods, unlike those used by valuation consultants. Moreover, one temporal analysis and another for different industries confer these outcomes consistency.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

URANS Analysis of a Launch Vehicle Aero-Acoustic Environment

  • Escartí-Guillem, Mara Salut
  • García-Raffi, L. M.|||0000-0003-3985-8453
  • Hoyas, Sergio|||0000-0002-8458-7288
[EN] Predicting and mitigating acoustic levels become critical because of the harsh acoustic environment during space vehicle lift-off. This paper aimed to study the aero-acoustic environment during a rocket lift-off. The sound propagation within a launch event was studied using dedicated computational fluid dynamics (CFD). The resolution of all the phenomena that occur is unfeasible. We discuss the turbulence simplification and propose a feasible simulation through an unsteady Reynolds-averaged Navier¿Stokes (URANS) model. The results were validated with experimental data showing a good correlation near the fairing surface and an improvable accuracy in the far field. To assess noise generation, the main shock waves were identified, and the evolution of the generated sound pressure was assessed. Moreover, vertical directivity was revealed by data analysis of the pressure field surrounding the fairing., This research was funded by the European Space Agency of Project REDLAUCH: Launch Sound Level Reduction under contract 4000126316/19/NL/LvH. The work was supported by the MICINN (grants: DIN2019-010877 and RTI2018-102256-B-100) and by the Barcelona Supercomputing Center under Project IM-2021-2-0017 Rocket launch aeroacoustics.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Evaluating energy financing considerations and sustainable energy innovation with the role of financial development and energy development

  • Barykin, Sergey Evgenievich
  • Sergeev, Sergey Mikhailovich
  • Mottaeva, Angela Bahauovna
  • Baydukova, Natalya Vladimirovna
  • Gubenko, Alexander Viktorovich
  • De la Poza, Elena|||0000-0003-2303-0811
[EN] The purpose of the study is to test the role of energy development in energy financing considerations for sustainable energy innovation and financial development. To achieve the study objective, a fuzzy decision-making modeling technique is applied. The results revealed that bank loans are now the main source of financing for innovation and creativity in Chinese business entities. Project-based financing might be replaced with collaborative and sustainable energy innovation (CSI), warranting energy development. Moreover, green financing loan schemes invest both public and private funds in sustainable energy innovation to capitalize on financial development through sustainable energy innovation. The consideration and application of financial consideration for sustainable energy innovation-financing projects or companies are limitless. Providing for screening energy development cooperation proposals with small financial payback hurdle rates might have large opportunity costs. There may be a case for governments to increase industrial growth, improve resource efficiency, and increase factor productivity while tackling climate change. Economic growth in China may have an even greater influence on environmental sustainability than in other countries. On such points, there is a need to pay the attention. If the suggested policy suggestions are implemented successfully, they would help to enhance the scope of financing considerations for sustainable energy innovation to uplift financial development through energy development mechanisms at the corporate level., The research is partially funded by the Ministry of Science and Higher Education of the Russian Federation under the strategic academic leadership program "Priority 2030" (Agreement. 075-152021-1333 dd 30.09.2021).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Experiences in Transdisciplinary Education for the Sustainable Development of the Built Environment, the ISAlab Workshop

  • Orozco-Messana, Javier|||0000-0001-8611-8816
  • De la Poza, Elena|||0000-0003-2303-0811
  • Calabuig-Moreno, Raimon|||0000-0003-0810-881X
[EN] There is a growing recognition and acceptance that society needs to develop new pathways to achieve a more sustainable;future. Our current model of development poses significant challenges when it comes to achieving a more just society based on respect for nature and human rights, and demands a sustainable economy supported by a new circular model supporting the UN sustainable development goals. Higher Education Institutions (HEIs) accordingly have developed Master programs that are responsible for providing fundamental services in the joint effort towards sustainability. Meanwhile, leading Universities around the world have developed other very relevant programs. The open and unstructured challenge of sustainability poses an obstacle to existing academic structures. Specifically, the built environment is one of the leading contributors to challenges addressed in the programs such as: Anthropogenic climate change, resource depletion, waste generation and pollution, poverty, and inequity. The Interdisciplinary Sustainable Architecture lab (ISAlab) explores these issues as part of a multidisciplinary approach involving the collaboration of leading Universities from different areas on the world through an innovative initiative. This paper explores the experiences of the ISAlab workshop, which has been taking place yearly in Valencia since 2017. The workshop draws together students from a range of disciplines from across engineering and science, law and the social sciences and from a range of countries and backgrounds, including North and South America, Europe, and Asia. Its purpose is to facilitate a rich co-creative learning environment led by (engineering) academic faculties from across Europe (Spain, the UK, France, Germany, Netherlands and Ireland) as well as North America (the US and Canada), as well as local experts who helped provide participants with appropriate context and guidance. The objective is educating future engineers that are capable of finding robust ways to implement sustainability at a practical level on the built environment, taking account of the multidisciplinary perspective and with the incentive of solving real-life problems., This research has been co-funded by the Erasmus+ KA2 program of the European Union under the "SAUNAC" project.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A neural network approach for chatter prediction in turning

  • Cherukuri, Harish
  • Schmitz, Tony L.
  • Pérez Bernabeu, Elena|||0000-0002-9221-7623
  • Sellés, M.A.|||0000-0002-0784-5757
[EN] Machining processes, including turning, are a critical capability for discrete part production. One limitation to high material removal rates and reduced cost in these processes is chatter, or unstable spindle speed-chip width combinations that exhibit self-excited vibration. In this paper, an artificial neural network (ANN) is applied to model turning stability. The analytical stability limit is used to generate a data set that trains the ANN. It is observed that the number and distribution of training points influences the ability of the ANN model to capture the smaller, more closely spaced lobes that occur at lower spindle speeds. Overall, the ANN is successful (>90% accuracy) at predicting the stability behavior after appropriate training., The authors gratefully acknowledge financial support from the UNC ROI program. Elena Perez-Bernabeu and Miguel Selles also acknowledge support from Universitat Politenica de Valencia (PAID-00-17). Additionally, some of the neural net figures and the 10-fold cross validation figures are based on the TikZ codes provided on StackExchange-TeX by various users. Harish Cherukuri would like to thank them for their valuable advice.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chemical Modifications of Globular Proteins Phototriggered by an Endogenous Photosensitizer

  • Reid, Lara O.
  • Dántola, M. Laura
  • Petroselli, Gabriela
  • Erra-Balsells, Rosa
  • Miranda Alonso, Miguel Ángel
  • Thomas, Andrés H.
  • Lhiaubet, Virginie Lyria|||0000-0002-8205-8892
[EN] The main goal of the present work was to investigate the damages photoinduced by pterin (Ptr), an endogenous photosensitizer present in human skin under pathological conditions, on a globular protein such as ubiquitin (Ub). Particular attention has been paid on the formation of covalent adducts between Ptr and the protein that can behave as photoantigen and provoke an immune system response. Here, a multifaceted approach including UV-visible spectrophotometry, fluorescence spectroscopy, electrophoresis, size exclusion chromatography, and mass spectrometry is used to establish the Ub changes triggered by UV-A irradiation in the presence of Ptr. Under anaerobic conditions, the only reaction corresponds to the formation of a covalently bound Ptr-Ub adduct that retains the spectroscopic properties of the free photosensitizer. A more complex scheme is observed in air-equilibrated solutions with the occurrence of three different processes, that is, formation of a Ptr-Ub adduct, dimerization, and fragmentation of the protein., The present work was partially supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-Grants PIP 112-200901-0304 and PIP 11220120100072CO), Agencia de Promocion Cientifica y Tecnologica (ANPCyT-Grants PICT-2015-1988 and PICT 2016-00130), Universidad Nacional de La Plata (UNLP-Grant X712 and X840), and Universidad de Buenos Aires (UBA-Grant 000110BA). Funding from the Programa CSIC de Cooperacion Cientifica para el Desarrollo (iCOOPLight project ref 20105CD0017) and Spanish government (PGC2018-096684-B-I00) is gratefully acknowledged. The Ultraflex II (Bruker) TOF/TOF mass spectrometer was supported by a grant from ANPCYT, PME2003 No. 125, and the ESI-MS Q Exactive, Thermo Scientific, by a grant from ANPCYT, PME2011-PPL2-0009, CEQUIBIEM, DQB, FCEN, UBA. The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia. This proteomics laboratory is a member of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and ERDF. L.O.R. thanks CONICET for doctoral research fellowships. RE-B, G.P., M.L.D., and A.H.T are research members of CONICET.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Structural-Transport Properties Relationships on Ce(1-x)Ln(x)O(2-delta) System (Ln = Gd, La, Tb, Pr, Eu, Er, Yb, Nd) and Effect of Cobalt Addition

  • Balaguer Ramirez, Maria|||0000-0002-7098-9235
  • Serra Alfaro, José Manuel|||0000-0002-1515-1106
  • Solis Díaz, Cecilia
A large series of doped cerias have been prepared by the coprecipitation method combined with impregnation and completely characterized in order to have an overall understanding of the structural, oxygen vacancy concentration, and transport properties relationships. Several lanthanides were incorporated in the fluorite structure, and the effects of the final sintering temperature (1073 and 1573 K) and the addition of cobalt oxide on the structural properties were studied. The chosen lanthanides (Gd, La, Tb, Pr, Eu, Er, Yb and Nd) included a large range of ionic radii and different metals exhibiting variable oxidation states under the typical operating conditions for these materials. The materials have been characterized by powder XRD, high-temperature XRD, micro- Raman spectroscopy, helium pycnometry, and dc conductivity. Transport properties were correlated with structural features induced by the different ionic radii and variable oxidation state of the dopants. The highest ionic conductivity was obtained for the less distorted cells (Gd- and Nd-doped ceria) which represent the optimum balance between Coulomb interactions, steric effects, and vacancy distribution. The lowest Ea value was found for materials with long cell parameters., Financial support by the Spanish Ministry for Science and Innovation (Project ENE2008-06302, ENE2011-24761 and Grant BES-2009-015835), Spanish Industry Ministry (Project IAP-560620-2008-17), and Instalaciones Inabensa S.A. is kindly acknowledged. Dr. Jose L. Jorda contributed to this work with HT-XRD diffraction experiments.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Pterin-photosensitization of thymine under anaerobic conditions in the presence of guanine

  • Estébanez, Sandra
  • Rivera, Ana M.
  • Recky, Jael R. Neyra
  • Thomas, Andres H.
  • Lorente, Carolina
  • Lhiaubet, Virginie Lyria|||0000-0002-8205-8892
[EN] Pterin (Ptr) is a model photosensitizer that acts mainly through type I mechanism and is able to photoinduce the one-electron oxidation of purine and pyrimidine nucleobases. However, under anaerobic conditions Ptr reacts with thymine (T) to form photoadducts (Ptr-T) but does not lead to the photodegradation of guanine (G), which is the nucleobase with the lowest ionization potential. Accordingly, G is thermodynamically able to reduce the radicals of the other nucleobases and has been described in this sense as the "hole sink" of the DNA double helix. Here we analyze by steady-state and time-resolved studies the effect of G in the anaerobic photosensitization of T by Ptr, using nucleotides and oligonucleotides of different sequences. We demonstrated that G is able to reduce T radicals but does not prevent the formation of Ptr-T adducts. Our results suggest that after the encounter between the excited Ptr and T, and completion of the electron transfer step, part of the radicals escape from the solvent cage, to further react with other species. However, a proportion of radicals do not escape and evolve to photoadducts before separation. We provide new evidence that contributes to understand the photosensitizing properties of Ptr in the absence of O-2, the mechanism of formation of photoadducts in the DNA and the protective role of G towards the photodamage in other nucleobases., The present work was partially supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-Grant P-UE 2017 22920170100100CO) , Agencia de Promocion Cientifica y Tecnologica (ANPCyT-Grant PICT 2015-1988, and PICT 2017-0925) , Universidad Nacional de La Plata (UNLP-Grant 11/X840) . Funding from the Program CSIC de Cooperacion Cientifica para el Desarrollo (iCOOP-Light project ref 20105CD0017) and Spanish Government (PGC2018-096684-B-I00) are gratefully acknowledged. S.E.R. and J.R.N.R. thanks ANPCyT and CONICET for doctoral research fellowships. A.M.R. thanks Universidad de Antioquia (Colombia) for research fellowship. C.L. and A.H.T. are research members of CONICET. V.L.V. is research member of CSIC.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Sustainable Energy Efficient Human-Centered Digital Solutions for ESG Megacities Development

  • Barykin, Sergey Evgenievich
  • Sergeev, Sergey Mikhailovich
  • Kapustina, Irina Vasilievna
  • Danilevich, Denis Vladimirovich
  • Mottaeva, Angela Bahauovna
  • Andreeva, Larisa Olegovna
  • Niyazbekova, Shakizada Uteulievna
  • Karmanova, Anna Evgenievna
  • De la Poza, Elena|||0000-0003-2303-0811
[EN] This study demonstrates algorithms that assist municipal administrations to make the best environmental decisions. The algorithms developed by large alpha-class municipal governments with assistance of department of environmental agency data analyst. Mathematical and econometric modeling techniques as well as optimum solution theories adhered to develop a model, and the criteria is functionality, which reflects a balance between maximum profit, comfort in living circumstances, the environment, and the need to avoid a market failure scenario. The ensuing results allow for the most optimal administrative decisions, such as the rate of environmental taxes. The empirical findings show that higher environmental, social and governance performance and digital finance has improved the corporate financing efficiency, as well as the influence of ESG performance on energy efficiency, all at a 1% significance level., The research was partially funded by the Ministry of Science and Higher Education of the Russian Federation under the strategic academic leadership program "Priority 2030" (Agreement 075-15-2021-1333 dated 30.09.2021).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Photochemical formation of a fluorescent thymidine-pterin adduct in DNA

  • Estébanez, Sandra
  • Lorente, Carolina
  • Gaspar Tosato, Maira
  • Miranda Alonso, Miguel Ángel
  • Thomas, Andrés H.
  • Marín García, Mª Luisa|||0000-0002-9789-8894
  • Lhiaubet, Virginie Lyria|||0000-0002-8205-8892
[EN] The photochemistry of the DNA biomacromolecule is an issue of paramount importance as it is part of the etiology of skin cancer development, being ultraviolet sunlight radiation the most relevant environmental carcinogen. Herein, we demonstrate the potential of pterin, an endogenous compound, to form covalent adduct under UVA irradiation with a short thymine oligomer as well as with the whole DNA polymer. Our approach is based on the spectroscopic features of pterin, which allow, by monitoring specific absorption or emission wavelengths, the following-up of the covalent binding. The results are confirmed by HPLC coupled with mass spectrometry, revealing the attachment of one or two pterin units to the homothymine 5-mer oligonucleotide. Altogether the findings point toward the role of pterin as endogenous sensitizer and genotoxic compound., The present work was partially supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-Grant PIP 112-200901-0304), Agencia de Promocion Cientifica y Tecnologica (ANPCyT-Grant PICT-2012-0508), Universidad Nacional de La Plata (UNLP-Grant X712). Funding from the Programa CSIC de Cooperacion Cientifica para el Desarrollo (iCOOPLight project ref 20105CD0017) and Spanish Government (CTQ2015-70164-P) are gratefully acknowledged. S.E.R. thanks ANPCyT and CONICET for doctoral research fellowships. M.G.T thanks CONICET for postdoctoral fellowship. C.L. and A.H.T. are research members of CONICET. The authors thank Dr. Mariana Vignoni (INIFTA, CONICET) and Nathalie Martins-Froment of the Service Commun de Spectrometrie de Masse (FR2599), Universite de Toulouse III (Paul Sabatier) for their crucial contributions in mass spectrometry measurements.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

An electroacoustic method for measuring airflow resistivity of porous sound-absorbing materials

  • Alba, Jesus|||0000-0002-4188-854X
  • del Rey, Romina|||0000-0001-5907-0677
  • Arenas, Jorge P.
  • Rodríguez-Vercher, Juan-Carlos
[EN] In this paper, a method for measuring the airflow resistivity of air-saturated porous sound-absorbing materials is presented. The method is based on a modification of the previous device developed by Dragonetti et al. The approach used in the present work involves a cavity and a Helmholtz resonator that are coupled through a loudspeaker so that the complete system behaves as a fourth-order symmetrical band-pass loudspeaker system. After a straightforward calibration, the airflow resistivity of a material sample is indirectly estimated from the direct measurement of the total electric impedance at the loudspeaker connection terminals. In this way, the use of microphones is not necessary, which makes its implementation very simple and inexpensive. Experimental results obtained with the present method agree well with those obtained through a standardized method as long as the values of the material's airflow resistance are not too high. (C) 2019 Elsevier Ltd. All rights reserved., The authors would like to gratefully acknowledge the support of CONICYT-FONDECYT under Grant 1171110 and to the Vicerectorate of R+i+t at Univ. Politecnica of Valencia, Grant PAID0017.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Machining Chatter Prediction Using a Data Learning Model

  • Cherukuri, Harish
  • Schmitz, Tony
  • Pérez Bernabeu, Elena|||0000-0002-9221-7623
  • Sellés, M.A.|||0000-0002-0784-5757
[EN] Machining processes, including turning, are a critical capability for discrete part production. One limitation to high material removal rates and reduced cost in these processes is chatter, or unstable spindle speed-chip width combinations that exhibit a self-excited vibration. In this paper, an artificial neural network (ANN)-a data learning model-is applied to model turning stability. The novel approach is to use a physics-based process model-the analytical stability limit-to generate a (synthetic) data set that trains the ANN. This enables the process physics to be combined with data learning in a hybrid approach. As anticipated, it is observed that the number and distribution of training points influences the ability of the ANN model to capture the smaller, more closely spaced lobes that occur at lower spindle speeds. Overall, the ANN is successful (>90% accuracy) at predicting the stability behavior after appropriate training., The authors gratefully acknowledge financial support fromtheUNCROI program. Elena Perez-Bernabeu and Miguel Selles also acknowledge support from Universitat Politecnica de Valencia (PAID-00-17). Additionally, some of the neural network and cross validation figures are based on the TikZ codes provided on StackExchange-TeX by various users. Harish Cherukuri would like to thank them for their valuable advice.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Assessing social performance of construction companies in public-works procurement: Data envelopment analysis based on the benefit of the doubt approach

  • Montalbán-Domingo, Laura|||0000-0002-9506-0350
  • García-Segura, Tatiana|||0000-0002-7059-0566
  • Sanz-Benlloch, Amalia|||0000-0001-8051-0649
  • Pellicer, Eugenio|||0000-0001-9100-0644
  • Torres-Machí, Cristina
  • Molenaar, Keith
[EN] There is an urgent need to improve the assessment of construction companies' Corporate Social Responsibility (CSR) in public-works procurement. Current procurement procedures assign a high level of subjectivity to CSR assessment and lack transparency. Existing research basically highlights the need to define weighting systems in which the importance of each social criterion is objective and based on the social weaknesses in the context of a project. In order to fulfill this gap, this research proposes a composite indicator for assessing CSR in public construction procurement. A Data Envelopment Analysis based on the Benefit of Doubt Approach (DEA-BOD) was chosen to define the weighting system based on the main social weaknesses that exist in the country where the contract is procured. The research employs simulation to assess the validity of this indicator. The results highlight that the use of national indices as a proxy for CSR indicators can be helpful in determining the level of importance of CSR in public procurement. The simulation showed that the proposed approach allows the objective comparison of CSR performance of construction companies, regardless of their size. This research assists decision-makers in properly integrating social sustainability in procurement procedures., The authors acknowledge the financial support of the Universitat Politecnica de Valencia (PAID -00-17) . The authors are grateful to the expert panel for their participation in this research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Virtual reality as a versatile tool for research, dissemination and mediation in the humanities, La realidad virtual como herramienta versátil de investigación, difusión y mediación en las humanidades

  • François, Paul
  • Leichman, Jeffrey
  • Laroche, Florent
  • Rubellin, Françoise
[EN] The VESPACE project aims to revive an evening of theatre at the Foire Saint-Germain in Paris in the 18th century, by recreating spaces, atmospheres and theatrical entertainment in virtual reality. The venues of this fair have disappeared without leaving any archaeological traces, so their digital reconstruction requires the use of many different sources, including the expertise of historians, historians of theatre and literature. In this article, we present how we have used video game creation tools to enable the use of virtual reality in three key stages of research in the human sciences and particularly in history or archaeology: preliminary research, scientific dissemination and mediation with the general public. In particular, we detail the methodology used to design a three-dimensional (3D) model that is suitable for both research and virtual reality visualization, meets the standards of scientific work regarding precision and accuracy, and the requirements of a real-time display. This model becomes an environment in which experts can be immersed within their fields of research and expertise, and thus extract knowledge reinforcing the model created –through comments, serendipity and new perspectives– while enabling a multidisciplinary workflow. We also present our tool for annotating and consulting sources, relationships and hypotheses in immersion, called PROUVÉ. This tool is designed to make the virtual reality experience go beyond a simple image and to convey scientific information and theories in the same way an article or a monograph does. Finally, this article offers preliminary feedback on the use of our solutions with three target audiences: the researchers from our team, the broader theatre expert community and the general public., [ES] El proyecto VESPACE tiene como objetivo revivir una velada de teatro en la Foire Saint-Germain de París en el siglo XVIII, recreando espacios, atmósferas y entretenimiento teatral en realidad virtual. Las sedes de esta feria han desaparecido sin dejar ningún rastro arqueológico, por lo que su reconstrucción digital requiere el uso de muy diversas fuentes, entre las que se encuentran expertos historiadores, historiadores del teatro y la literatura. En este artículo presentamos cómo hemos utilizado las herramientas de creación de videojuegos que posibilitan el uso de la realidad virtual en tres etapas clave de la investigación en las ciencias humanas y particularmente en historia o arqueología: investigación preliminar, divulgación científica y mediación con el público en general. En particular, detallamos la metodología utilizada para diseñar un modelo tridimensional (3D) que sea adecuado tanto para la investigación como para la visualización mediante realidad virtual, que cumpla con los estándares del trabajo científico en cuanto a precisión y exactitud, y los requisitos de una visualización en tiempo real. Este modelo se convierte en un entorno en el que los expertos pueden sumergirse dentro de sus campos de investigación y especialización, y así extraer conocimiento reforzando el modelo creado –a través de comentarios, serendipia y nuevas perspectivas– al tiempo que posibilita un flujo de trabajo multidisciplinar. También presentamos nuestra herramienta de anotación y consulta de fuentes, relaciones e hipótesis en inmersión, denominada PROUVÉ. Esta herramienta está diseñada para hacer que la experiencia de la realidad virtual vaya más allá de una simple imagen y que transmita información científica y teorías de la misma manera que lo hace un artículo o una monografía. Finalmente, este artículo ofrece comentarios preliminares sobre el uso de nuestras soluciones con tres públicos objetivo: los investigadores de nuestro equipo, la comunidad de expertos en teatro (más amplia) y el público en general., This research was funded in France by the Agence Nationale de la Recherche, with the CIRESFI project, Grant No. ANR 14-CE31-0017, and the ReSeed project, Grant No. ANR 16-CE38-0005, and a grant from RFI Pays de la Loire "Ouest Industries Créatives" and the École Centrale de Nantes for the AAP 2017 VESPACE project. In the United States, the project is supported by the National Endowment for Humanities, Grant No. NEH HAA-266501-19.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Resilient structures in the seismic retrofitting of RC frames: A case study

  • Pallarés Rubio, Francisco Javier|||0000-0003-4298-2287
  • Pallarés Rubio, Luis|||0000-0003-2126-2387
  • Domínguez, David
[EN] It is very important to allocate valuable resources efficiently when reconstructing buildings after earthquake damage. This paper proposes the use of a simple seismic retrofitting system to make buildings more resilient than the stiffer systems such as the shear walls implemented in Chile after the earthquake in 2010. The proposal is based on the use of steel chevron-type braces in RC buildings as a dual system to improve the seismic performance of multistory buildings. A case study was carried out to compare the proposal with the shear wall solution for the typical seismic Chilean RC building from the structural and economic perspectives. The results show that it is more resilient than other stiffer seismic solutions, such as shear walls, reduces the demand, minimizes seismic damage, gives reliable earthquake protection and facilitates future upgrades and repairs while achieving the level of immediate occupancy without the costs of the shear walls system., The authors wish to thank the Universitat Politecnica de Valencia (UPV) (PAID-00-17), the Generalitat Valenciana (GVA) and the Spanish Ministry of Economy and Competitiveness (MINECO) for the grants and funds received to support this investigation: BIA2012-35186, BIA2015-70651-R, BEST/2018.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Remodeling the tumor immune microenvironment with lipid nanoparticles

  • Martínez-Latorre, Javier|||0000-0001-5421-5371
[ES] Esta tesis doctoral, titulada "Remodelación del microambiente inmunitario tumoral con nanopartículas lipídicas", explora el desarrollo de nuevas estrategias inmunoterapéuticas contra el cáncer, tanto a nivel terapéutico como de métodos de administración. En concreto, el trabajo investiga enfoques alternativos y relativamente poco explorados, como las inmunoterapias basadas en macrófagos y la inmunoterapia mediada por antígenos exógenos, que tratan de superar las principales limitaciones de las modalidades inmunoterapéuticas actuales. Paralelamente, la tesis evalúa las nanopartículas lipídicas (LNP) como sistemas de administración de genes no virales para la inmunoterapia. El primer capítulo experimental describe el desarrollo de una novedosa plataforma LNP para la inmunoterapia basada en macrófagos. Las LNP cargadas con ADN plasmídico o ARNm de luciferasa se funcionalizaron con ácido fólico (FA) para dirigirse a las células cancerosas pancreáticas que expresan el receptor de folato y con un anticuerpo anti-CD47 (aCD47) para bloquear la evasión inmunitaria mediada por CD47. Los resultados demuestran una transfección eficaz de las células de cáncer de páncreas, con las LNP cargadas con ARNm superando a las formulaciones basadas en plásmidos. Además, la funcionalización con FA mejoró la captación dirigida de LNP in vitro y la funcionalización con aCD47 restauró la fagocitosis de las células tumorales por los macrófagos in vitro. Los experimentos in vivo en modelos de xenoinjertos Capan-2 de ratón con LNP-ARNm-FA-aCD47 demostraron la expresión in vivo de luciferasa y promovieron un cambio hacia un fenotipo de macrófagos proinflamatorio M1 dentro del microambiente tumoral. En conjunto, estos resultados presentan una plataforma LNP optimizada, capaz de inmunomodular los macrófagos asociados a tumores. El segundo capítulo experimental presenta una novedosa inmunoterapia mediada por antígenos exógenos basada en el epítopo alpha-Gal (galactosa-alpha-1,3-galactosa). El epítopo alpha-Gal es altamente inmunogénico en humanos y provoca fuertes respuestas debido a anticuerpos preexistentes. Se desarrollaron LNP que codifican el ARNm de la alpha-1,3-galactosiltransferasa (alpha-GT) para permitir la biosíntesis endógena de alpha-Gal en la superficie de las células tumorales. El tratamiento con estas LNP indujo con éxito la expresión de alpha-Gal en líneas celulares cancerosas murinas y humanas y promovió el reclutamiento de anticuerpos anti-alpha-Gal humanos naturales hacia las células tumorales. Estos resultados identifican a la LNP alpha como una plataforma inmunoterapéutica prometedora que aprovecha la inmunidad humoral preexistente. El tercer capítulo experimental describe una novedosa inmunoterapia mediada por antígenos exógenos basada en la proteína hemaglutinina (H) del virus del sarampión. La proteína H es un antígeno altamente inmunogénico en humanos debido a la vacunación generalizada contra el virus del sarampión. Se formularon LNP que codifican la proteína H y se demostró que transfectan eficazmente tanto cultivos celulares cancerosos bidimensionales como esferoides tumorales tridimensionales. Además, la administración in vivo de LNP H en ratones vacunados contra el sarampión con tumores de melanoma B16-BL6 dio lugar a una disminución significativa del crecimiento tumoral. Este efecto terapéutico está asociado con una fuerte infiltración intratumoral de linfocitos T citotóxicos CD8+, un cambio en la proporción de células T CD8/CD4 y la producción ex vivo de citocinas proinflamatorias tras la reactivación del antígeno, características distintivas de una potente respuesta inmunitaria mediada por células T CD8+. En conjunto, estos resultados ponen de relieve el potencial de LNP H como nueva estrategia para mejorar la inmunogenicidad tumoral y provocar fuertes respuestas inmunitarias antitumorales., [EN] This doctoral thesis, entitled "Remodeling the Tumor Immune Microenvironment with Lipid Nanoparticles", explores the development of novel cancer immunotherapeutic strategies at both the therapeutic and delivery levels. Specifically, the work investigates alternative and comparatively underexplored approaches, including macrophage-based immunotherapies and exogenous antigen-mediated immunotherapy, which seek to overcome key limitations of current immunotherapeutic modalities. In parallel, the thesis evaluates lipid nanoparticles (LNPs) as non-viral gene delivery systems for immunotherapy. The first experimental chapter describes the development of a novel LNP platform for macrophage-based immunotherapy. LNPs loaded with either luciferase-encoding plasmid DNA or mRNA were functionalized with folic acid (FA) for targeting folate receptor-expressing pancreatic cancer cells and with an anti-CD47 antibody (aCD47) to block CD47-mediated immune evasion. The results demonstrate efficient transfection of pancreatic cancer cells, with mRNA-loaded LNPs outperforming plasmid-based formulations. Moreover, the functionalization with FA enhanced targeted uptake of LNPs in vitro and aCD47 functionalization restored the phagocytosis of tumor cells by macrophages in vitro. In vivo experiments in mouse Capan-2 xenograft models with LNP-mRNA-FA-aCD47 demonstrated in vivo expression of luciferase and promoted a shift to a pro-inflammatory, M1-like macrophage phenotype within the tumor microenvironment. Together, these results present an optimized LNP platform capable of immunomodulating tumor-associated macrophages. The second experimental chapter presents a novel exogenous antigen-mediated immunotherapy based on the alpha-Gal epitope (galactose-alpha-1,3-galactose). alpha-Gal epitope is highly immunogenic in humans and elicits strong pre-existing antibody responses. LNPs encoding alpha-1,3-galactosyltransferase (alpha-GT) mRNA were developed to enable endogenous alpha-Gal biosynthesis on tumor cell surfaces. Treatment with these LNPs successfully induced alpha-Gal expression in both murine and human cancer cell lines and promoted the recruitment of naturally occurring human anti-alpha-Gal antibodies to tumor cells. These results identify LNP alpha as a promising immunotherapeutic platform that exploits pre-existing humoral immunity. The third experimental chapter describes a novel exogenous antigen-mediated immunotherapy based on the hemagglutinin (H) protein of the measles virus. H protein is a highly immunogenic antigen in humans due to widespread vaccination against measles virus. LNPs encoding H protein were formulated and shown to efficiently transfect both two-dimensional cancer cell cultures and three-dimensional tumor spheroids. Moreover, in vivo administration of H-expressing LNPs in measles-vaccinated mice bearing B16-BL6 melanoma tumors resulted in significant tumor growth delay. This therapeutic effect is associated with robust intratumoral infiltration of CD8+ cytotoxic T lymphocytes, a shift in the CD8/CD4 T cell ratio, and ex vivo production of pro-inflammatory cytokines upon antigen recall, hallmarks of a potent CD8+ T cell-mediated immune response. Together, these results highlight the potential of LNP H as a novel strategy to enhance tumor immunogenicity and elicit strong antitumor immune responses. We hope that the results obtained in this doctoral thesis will demonstrate the versatility of LNP-based platforms and support the development of innovative cancer immunotherapies that leverage alternative immunotherapeutic strategies, such as macrophage-based approaches and exogenous antigen-mediated immunotherapy., [CA] Esta tesi doctoral, titulada «Remodelació del microambient immunitari tumoral amb nanopartícules lipídiques», explora el desenvolupament de noves estratègies immunoterapèutiques contra el càncer, tant a nivell terapèutic com de mètodes d'administració. En concret, el treball investiga enfocaments alternatius i relativament poc explorats, com les immunoteràpies basades en macròfags i la immunoteràpia mediada per antígens exògens, que tracten de superar les principals limitacions de les modalitats immunoterapèutiques actuals. Paral·lelament, la tesi avalua les nanopartícules lipídiques (LNP) com a sistemes d'administració de gens no virals per a la immunoteràpia. El primer capítol experimental descriu el desenvolupament d'una nova plataforma LNP per a la immunoteràpia basada en macròfags. Les LNP carregades amb ADN plasmídic o ARNm de luciferasa es van funcionalitzar amb àcid fòlic (FA) per a dirigir-se a les cèl·lules canceroses pancreàtiques que expressen el receptor de folat i amb un anticòs anti-CD47 (aCD47) per a bloquejar l'evasió immunitària mediada per CD47. Els resultats demostren una transfecció eficaç de les cèl·lules de càncer de pàncrees, amb les LNP carregades amb ARNm superant a les formulacions basades en plasmidis. A més, la funcionalització amb FA va millorar la captació dirigida de LNP in vitro i la funcionalització amb aCD47 va restaurar la fagocitosi de les cèl·lules tumorals pels macròfags in vitro. Els experiments in vivo en models de xenotrasplantament Capan-2 de ratolí amb LNP-ARNm-FA-aCD47 van demostrar l'expressió in vivo de luciferasa i van promoure un canvi cap a un fenotip de macròfags proinflamatori M1 dins del microambient tumoral. En conjunt, aquests resultats presenten una plataforma LNP optimitzada, capaç de immunomodular els macròfags associats a tumors. El segon capítol experimental presenta una nova immunoteràpia mediada per antígens exògens basada en el epítop alpha-Gal (galactosa-¿-1,3-galactosa). El epítop alpha-Gal és altament immunogènic en humans i provoca fortes respostes a causa d'anticossos preexistents. Es van desenvolupar LNP que codifiquen el ARNm de la ¿-1,3-galactosiltransferasa (¿-GT) per a permetre la biosíntesi endògena de ¿-Gal en la superfície de les cèl·lules tumorals. El tractament amb estes LNP va induir amb èxit l'expressió de ¿-Gal en línies cel·lulars canceroses murines i humanes i va promoure el reclutament d'anticossos anti-¿-Gal humans naturals cap a les cèl·lules tumorals. Estos resultats identifiquen a la LNP alpha com una plataforma immunoterapèutica prometedora que aprofita la immunitat humoral preexistent. El tercer capítol experimental descriu una nova immunoteràpia mediada per antígens exògens basada en la proteïna hemaglutinina (H) del virus de la xarampió. La proteïna H és un antigen altament immunogènic en humans a causa de la vacunació generalitzada contra el virus de la pallola. Es van formular LNP que codifiquen la proteïna H i es va demostrar que transfecten eficaçment tant cultius cel·lulars cancerosos bidimensionals com esferoides tumorals tridimensionals. A més, l'administració in vivo de LNP H en ratolins vacunats contra la pallola amb tumors de melanoma B16-BL6 va donar lloc a una disminució significativa del creixement tumoral. Aquest efecte terapèutic està associat amb una forta infiltració intratumoral de limfòcits T citotòxics CD8+, un canvi en la proporció de cèl·lules T CD8/CD4 i la producció ex vivo de citocines proinflamatòries després de la reactivació de l'antigen, característiques distintives d'una potent resposta immunitària mediada per cèl·lules T CD8+. En conjunt, aquests resultats posen en relleu el potencial de LNP H com a nova estratègia per millorar la immunogenicitat tumoral i provocar fortes respostes immunitàries antitumorals. Esperem que els resultats obtinguts en aquesta tesi doctoral demostren la versatilitat de les plataformes basades en LNP i recolzen el desenvolupament d'immunoteràpies innovadores contra el càncer., This research was supported by European Union’s Horizon 2020 research and innovation programme under grant agreement No 899708 (ULISES). The work has also received funding from projects PID2020-119692RB-C22, PID2023-146637OB-C22, PID2021-128141OBC22, PID2021-126304OB-C41 and PID2024-155683OB-C41 funded by MCIN-Ministerio de Ciencia e Innovación and by the European Regional Development Fund—A way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012) and (RD21/0017/0012) Instituto de Salud Carlos III, the Generalitat de Catalunya (SGR21/01169). The research leading to these results has also received funding from “la Caixa” Foundation under agreement LCF/PR/SP23/52950009. The Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.M-L. is grateful to the Spanish MECD for his FPU grant (FPU19/06219). PM.S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). We also acknowledge the support of CERCA Programme/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Fostering innovation through stakeholders&apos, engagement at the healthcare industry: Tapping the right key.

  • Segarra-Oña, Marival|||0000-0001-9674-9056
  • Peiró Signes, Angel|||0000-0002-1549-6972
  • Verma, Rohit
[EN] In this paper we investigate to which point each of the healthcare industry's stakeholders are influencing the final innovation outputs. We propose and test a model that puts together stakeholders' engagement, innovation objectives and innovation outputs. We analyze data from 400+ healthcare Spanish companies using Partial Least Squared modelling technique. Results show that stakeholders' engagement is crucial to orientate innovation objectives that are directly and positively related to innovation outputs. Also, results push to a higher implication of society in the co-creation and participation in innovation activities in the healthcare industry highlighting its importance as, both, triggers and the most benefited recipients. This paper uncovers the relationship among healthcare stakeholders and innovation outputs and also answers another research question-which stakeholders have a stronger relationship with innovation outputs. Implications suggest that healthcare industry managers and policy makers should build on the relationship with clients/customers/patients/final users as innovation-related information inputs as an effective way to improve their innovation outputs. (C) 2020 Elsevier B.V. All rights reserved, The authors would like to thank the Cornell Institute for Healthy Futures, CIHF, for hosting Prof Segarra-Oria and Prof Peiro-Signes. Also the Cornell SC Johnson College of Business for inviting Prof Peiro-Signes and Prof Segarra-Ofia as academic scholars and the Universitat Politecnica de Valencia for subsidising the research stage of Prof. Segarra-Ofia (PAID-00-17).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Cobalt(II) Bipyrazolate Metal-Organic Frameworks as Heterogeneous Catalysts in Cumene Aerobic Oxidation: A Tag-Dependent Selectivity

  • Nowacka, Anna Elzbieta
  • Vismara, R.
  • Mercuri, G.
  • Moroni, M.
  • Domasevitch, K.
  • di Nicola, C.
  • Pettinari, C.
  • Giambastiani, G.
  • Galli, S.
  • Rossin, A.
  • Palomino Roca, Miguel|||0000-0003-2983-1038
  • Llabrés i Xamena, Francesc Xavier|||0000-0002-4238-5784
[EN] Three metal-organic frameworks with the general formula Co(BPZX) (BPZX(2-) = 3-X-4,4'-bipyrazolate, X = H, NH2, NO2) constructed with ligands having different functional groups on the same skeleton have been employed as heterogeneous catalysts for aerobic liquid-phase oxidation of cumene with O-2 as oxidant. O-2 adsorption isotherms collected at p(O2) = 1 atm and T = 195 and 273 K have cast light on the relative affinity of these catalysts for dioxygen. The highest gas uptake at 195 K is found for Co(BPZ) (3.2 mmol/g (10.1 wt % O-2)), in line with its highest BET specific surface area (926 m(2)/g) in comparison with those of Co(BPZNH(2)) (317 m(2)/g) and Co(BPZNO(2)) (645 m(2)/g). The O-2 isosteric heat of adsorption (Q(2)) trend follows the order Co(BPZ) > Co(BPZNH(2)) > Co(BPZNO(2)). Interestingly, the selectivity in the cumene oxidation products was found to be dependent on the tag present in the catalyst linker: while cumene hydroperoxide (CHP) is the main product obtained with Co(BPZ) (84% selectivity to CHP after 7 h, p(O2) = 4 bar, and T = 363 K), further oxidation to 2-phenyl-2-propanol (PP) is observed in the presence of Co(BPZNH(2)) as the catalyst (69% selectivity to PP under the same experimental conditions)., S.G., R.V., and M.M. acknowledge Universita dell'Insubria for partial funding. G.G. thanks the Italian MIUR through the PRIN 2017 Project Multi-e: Multielectron Transfer for the Conversion of Small Molecules: an Enabling Technology for the Chemical Use of Renewable Energy (20179337R7) for financial support. G.G. thanks the TRAINER project (Catalysts for Transition to Renewable Energy Future) ref. ANR-17-MPGA-0017 for support. C.P. thanks the University of Camerino and the Italian MIUR throughout the PRIN 2015 Project Towards a Sustainable Chemistry (20154 x 9ATP_002). This project has also received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 641887 (project acronym: DEFNET) and the Spanish Government through projects MAT2017-82288-C2-1-P and Severo Ochoa (SEV-2016-0683). Professor Norberto Masciocchi (University of Insubria, Como, Italy) is acknowledged for fruitful discussions. The authors are also grateful to Dr. Giulia Tuci (CNR-ICCOM Florence, Italy) for help with the XPS curve fitting. The Microscopy Service of the Universitat Politècnica de València is gratefully acknowledged for the electron microscopy measurements.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial

  • del Canto Serrano, Irene
  • Santas, Enrique
  • Cardells, Ingrid
  • Miñana, Gema
  • Palau, Patricia
  • Llàcer, Pau
  • Fácila, Lorenzo
  • López-Vilella, Raquel
  • Almenar, Luis
  • Bodí, Vicent
  • López-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Sanchis, Juan
  • Maceira, Alicia M.
  • Moratal, David|||0000-0002-2825-3646
[EN] BACKGROUND: The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial-IRON trial showed short-term cardiac magnetic resonance (CMR) changes suggesting myocardial iron repletion following administration of FCM but failed to find a significant increase in left ventricular ejection fraction in the whole sample. Conversely, the strain assessment could evaluate more specifically subtle changes in contractility. In this subanalysis, we aimed to evaluate the effect of FCM on the short-term left and right ventricular CMR feature tracking derived strain. METHODS AND RESULTS: This is a post hoc subanalysis of the double-blind, placebo-controlled, randomized clinical trial that enrolled 53 ambulatory patients with heart failure and left ventricular ejection fraction <50%, and iron deficiency [Myocardial-IRON trial (NCT03398681)]. Three-dimensional left and 2-dimensional right ventricular CMR tracking strain (longitudinal, circumferential, and radial) changes were evaluated before, 7 and 30 days after randomization using linear mixed-effect analysis. The median (interquartile range) age of the sample was 73 years (65-78), and 40 (75.5%) were men. At baseline, there were no significant differences in CMR feature tracking strain parameters across both treatment arms. At 7 days, the only global 3-dimensional left ventricular circumferential strain was significantly higher in the FCM treatment-arm (difference: -1.6%, P=0.001). At 30 days, and compared with placebo, global 3-dimensional left ventricular strain parameters significantly improved in those allocated to FCM treatment-arm [longitudinal (difference: -2.3%, P<0.001), circumferential (difference: -2.5%, P<0.001), and radial (difference: 4.2%, P=0.002)]. Likewise, significant improvements in global right ventricular strain parameters were found in the active arm at 30 days (longitudinal [difference: -3.3%, P=0.010], circumferential [difference: -4.5%, P<0.001], and radial [difference: 4.5%, P=0.027]). CONCLUSIONS: In patients with stable heart failure, left ventricular ejection fraction <50%, and iron deficiency, treatment with FCM was associated with short-term improvements in left and right ventricular function assessed by CMR feature tracking derived strain parameters., This work was supported in part by an unrestricted grant from Vifor Pharma, CIBER Cardiovascular [grant numbers 16/11/00420 and 16/11/00403], Unidad de Investigacion Clinica y Ensayos Clinicos INCLIVA Health Research Institute, Spanish Clinical Research Network (SCReN; PT13/0002/0031 and PT17/0017/0003), cofounded by Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III, and Proyectos de Investigacion de la Seccion de Insuficiencia Cardiaca 2017 from Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Deflector shape impact on aero-acoustic noise generation and propagation

  • Escartí-Guillem, Mara Salut
  • Hoyas, Sergio|||0000-0002-8458-7288
  • García-Raffi, L. M.|||0000-0003-3985-8453
[EN] The acoustic pressure level generated during lift-off and the associated vibrations can significantly affect the payload of a launch vehicle. Optimizing the plume deflector is one of the most effective methods to reduce this noise. Considering the Vega launcher as a case of study, different deflectors are studied: flat, inclined at 30 degrees, and wedge. The approach followed is to use the unsteady Navier-Stokes equations to solve both the noise generation and the propagation. First, it has been observed that the blast wave, due to the ignition overpressure, is independent of the deflector geometry. However, the predominant acoustic waves are due to the impact of the jet with the deflectors. The analysis has shown that the flat deflector generates more shock waves and propagates the acoustic waves equally in all directions so that more acoustic loads reach the fairing. The inclined deflector causes a plate shock and intermediate tail shocks and redirects the flow towards one side of the launcher. Finally, the wedge deflector generates a detached shock wave with a higher pressure increase than the inclined deflector. However, as the flow is redirected towards the two sides, a lower OASPL reaches the fairing. In the same way, the pressure distribution over the fairing surface has shown that the wedge deflector is acoustically more efficient for this case of study. The acoustic effectiveness of deflectors has been demonstrated compared to the case without a deflector. Therefore, deflectors are advised to be included on the launch platform to improve payload comfort and reliability on the launchers., Authors acknowledge the support of the European Space Agency, France under contract 4000126316/19/NL/LvH of project REDLAUCH: Launch Sound Level Reduction. This work has the support of grant PID2021-128676OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe", by the "European Union". The work was supported by the Spanish Ministry of Science and Innovation through project PID2019-109175GB-C22 Mineco/FEDER. Part of the simulations have been performed on MareNostrum (BSC) with the project IM-2021-2-0017 Rocket launch aeroacoustic. L.M. Garcia-Raffi is grateful for the partial support by the Grant PID2020-112759GB-I00 funded by MCIN/AEI/10.13039/501100011033.r MareNostrum (BSC) with the project IM-2021-2-0017 Rocket launch aeroacoustic. L.M. Garcia-Raffi is grateful for the partial support by the Grant PID2020-112759GB-I00 funded by MCIN/AEI/10.13039/501100011033.
riUAL. Repositorio Institucional de la Universidad de Almería
Publicación Artículo científico (JournalArticle)

Comb-like dextran copolymers: A versatile strategy to coat highly porous MOF nanoparticles with a PEG shell

  • Cutrone, Giovanna
  • Qiu, Jingwen
  • Menendez-Miranda, Mario
  • Casas Solvas, Juan Manuel
  • Aykac, Ahmet
  • Li, Xue
  • Foulkes, Daniel
  • Moreira Alvarez, Borja
  • Encinar, Jorge R.
  • Catherine, Ladavière
  • Desmaële, Didier
  • Vargas Berenguel, Antonio
  • Gref, Ruxandra
Nanoparticles made of metal-organic frameworks (nanoMOFs) are becoming of increasing interest as drug carriers. However, engineered coatings such as poly(ethylene glycol) (PEG) based ones are required to prevent nanoMOFs recognition and clearance by the innate immune system, a prerequisite for biomedical applications. This still presents an important challenge due to the highly porous structure and degradability of nanoMOFs. We provide here a proof of concept that the surface of iron-based nanoMOFs can be functionalized in a rapid, organic solvent-free and non-covalent manner using a novel family of comb-like copolymers made of dextran (DEX) grafted with both PEG and alendronate (ALN) moieties, which are iron complexing groups to anchor to the nanoMOFs surface. We describe the synthesis of DEX-ALN-PEG copolymers by click chemistry, with control of both the amount of PEG and ALN moieties. Stable DEX-ALN-PEG coatings substantially decreased their internalization by macrophages in vitro, providing new perspectives for biomedical applications.
riUAL. Repositorio Institucional de la Universidad de Almería
Publicación Artículo científico (JournalArticle)

Self-assembled multifunctional core–shell highly porous metal–organic framework nanoparticles

  • Qiu, Jingwen
  • Li, Xue
  • Steenkeste, Karine
  • Barroca-Aubry, Nadine
  • Aymes-Chodur, Caroline
  • Roger, Philippe
  • Casas Solvas, Juan Manuel
  • Vargas Berenguel, Antonio
  • Rihouey, Christophe
  • Picton, Luc
  • Gref, Ruxandra
Core-shell nanoparticles (NPs) are attracting increasing interest in nanomedicine as they exhibit unique properties arising from the combined assets of core and shell materials. Porous nanoscale metal–organic frameworks (nanoMOFs) are able to incorporate with high payloads a large variety of drugs. Like other types of NPs, nanoMOFs need to be functionalized with engineered coatings to ensure colloidal stability, control in vivo fate and drug release. To do so, a novel biodegradable cyclodextrin (CD)-based shell was designed in this study. Water soluble γ-CD-citrate oligomers grafted or not with fluorophores were successfully synthesized using citric acid as crosslinker and efficiently anchored onto the surface of porous nanoMOFs. As compared to monomeric CDs, the oligomeric CD coatings could offer higher interaction possibilities with the cores and better possibilities to graft functional moieties such as fluorescent molecules. The amounts of γ-CD-citrate oligomers onto the nanoMOFs were as high as 53 ± 8 wt%. The yield reached up to 86% in the optimized system. These core–shell nanocomposites were stable upon storage, in contrast to the naked nanoMOFs. In addition, the presence of the coating prevented the doxorubicin (DOX)-loaded nanoMOFs from aggregation. Moreover, due to the presence of fluorophores conjugated to the shell, fluorescence-lifetime microscopy enabled deciphering the coating mechanism. DOX loadings reached 48 ± 10 wt% after 24 h incubation with the drug solution. After coating for additional 24 h, DOX loadings reached 65 ± 8 wt%.
Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Time-domain phenomenological model of gravitational-wave subdominant harmonics for quasicircular nonprecessing binary black hole coalescences

  • Estellés, Héctor
  • Husa, Sascha
  • Colleoni, Marta
  • Keitel, David
  • Mateu-Lucena, Maite
  • García-Quirós, Cecilio
  • Ramos-Buades, Antoni
  • Borchers, Angela
[eng] In this work we present an extension of the time domain phenomenological model \texttt{IMRPhenomT} for gravitational wave signals from binary black hole coalescences to include subdominant harmonics, specifically the (l=2, m=\pm 1), (l=3, m=\pm 3), (l=4, m=\pm 4) and (l=5, m=\pm 5) spherical harmonics. We also improve our model for the dominant (l=2, m=\pm 2) mode and discuss mode mixing for the (l=3, m=\pm 2) mode. The model is calibrated to numerical relativity solutions of the full Einstein equations up to mass ratio 18, and to numerical solutions of the Teukolsky equations for higher mass ratios. This work complements the latest generation of traditional frequency domain phenomenological models (IMRPhenomX), and provides new avenues to develop computationally efficient models for gravitational wave signals from generic compact binaries.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Immunoglobulin G4-related Disease: What an Allergist Should Know

  • Carballo, I.
  • González Quintela, Arturo
  • Sopeña Pérez-Argüelles, Bernardo
  • Vidal Pan, Carmen
Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory disorder that begins in 1 or more organs as inflammatory tumors that progress toward fibrosis. It is often accompanied by elevated serum IgG4. IgG4-RD was first described in 2003 as a new concept encompassing a number of immunoallergic diseases that had previously been considered unrelated. IgG4-RD mainly affects middleaged and older men. It consists of upregulation and expansion of CD4+ cytotoxic T lymphocytes, oligoclonal plasmablasts, and other inflammatory cells that infiltrate affected tissues and induce inflammation, organ dysfunction, and fibrosis. Symptoms depend on the location, severity, and extent of the disease. Virtually any organ can be affected, including the pancreas, salivary glands, lacrimal glands, thyroid gland, retro-orbital tissue, lymph nodes, retroperitoneum, mediastinum, lung, kidney, aorta, serosal surfaces, and meninges. Patients with widespread disease may present general symptoms. At least 30%-40% of patients are atopic or display atopic traits such as eosinophilia and elevated serum IgE levels. Additional laboratory features include increased serum IgG4 concentrations, increased blood IgG4-plasmablasts, hypergammaglobulinemia, and hypocomplementemia. Diagnosis of IgG4-RD is based on a clinicopathological correlation. Lymphoplasmacytic infiltrate with abundant IgG4-positive plasma cells, storiform-type fibrosis, obliterative phlebitis, and tissue eosinophilia are the pathological hallmarks. Therapy for IgG4-RD is based primarily on corticosteroids but may include additional immunomodulatory drugs and monoclonal antibodies such as rituximab. In individuals with allergic features, IgG4-RD should be suspected when a history of unexplained swelling is observed in 1 or more organs, particularly if they respond to corticosteroids and the patients are men in the sixth decade of life and beyond.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease

  • García-Cárceles, Javier
  • Vázquez-Villa, Henar
  • Brea Floriani, José Manuel
  • Ladron de Guevara-Miranda, David
  • Cincilla, Giovanni
  • Sánchez-Martínez, Melchor
  • Sánchez-Merino, Anabel
  • Algar, Sergio
  • Frailes, María Teresa de los
  • Roberts, Richard S.
  • Ballesteros, Juan A.
  • Rodríguez de Fonseca, Fernando
  • Benhamú, Bellinda
  • Loza García, María Isabel
  • López-Rodríguez, María L.
Tolerance development caused by dopamine replacement with l-DOPA and therapeutic drawbacks upon activation of dopaminergic receptors with orthosteric agonists reveal a significant unmet need for safe and effective treatment of Parkinson’s disease. In search for selective modulators of the D1 receptor, the screening of a chemical library and subsequent medicinal chemistry program around an identified hit resulted in new synthetic compound 26 [UCM-1306, 2-(fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl] that increases the dopamine maximal effect in a dose-dependent manner in human and mouse D1 receptors, is inactive in the absence of dopamine, modulates dopamine affinity for the receptor, exhibits subtype selectivity, and displays low binding competition with orthosteric ligands. The new allosteric modulator potentiates cocaine-induced locomotion and enhances l-DOPA recovery of decreased locomotor activity in reserpinized mice after oral administration. The behavior of compound 26 supports the interest of a positive allosteric modulator of the D1 receptor as a promising therapeutic approach for Parkinson’s disease.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Relationship Between Immunoglobulin E Deficiency and Autoimmune Disease: The Paradigm of Primary Biliary Cholangitis

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions

  • Alende-Castro, V.
  • Alonso Sampedro, Manuela
  • Fernández Merino, Carmen
  • Sánchez-Castro, Juan José
  • Sopeña Pérez-Argüelles, Bernardo
  • Gude Sampedro, Francisco
  • González Quintela, Arturo
Background: Measurements of C-reactive protein (CRP) concentration and erythrocyte sedimentation rate (ESR) are frequently ordered jointly in clinical practice. Aim: To investigate the factors associated with discordances between CRP concentration and ESR in adults. Methods: We conducted a cross-sectional study of 1472 adults with no known inflammatory disorders (44.5% male; median age, 52 years; range, 18-91 years), randomly selected from a municipality in Spain. The participants underwent simultaneous measurements of ESR, serum CRP, and interleukin-6 concentrations. Alcohol consumption, smoking, and physical activity were evaluated by questionnaire. Body mass index (BMI) measurement and metabolic syndrome criteria were available for all participants. Results: Most (n = 1123, 74.9%) of the participants showed normal CRP and ESR values. Sixty-nine (4.6%) participants showed high CRP and ESR values. Seventy-two (4.8%) participants showed a discordant pattern of high ESR and normal CRP values, which was associated with age after adjusting for sex, alcohol consumption, physical activity, BMI, and the presence of metabolic syndrome (odds ratio [OR], 1.052; 95% CI, 1.034-1.071; P < .001). A total of 208 (13.8%) participants showed a discordant pattern of high CRP and normal ESR values, which was associated with BMI after adjusting for covariates (OR, 1.099; 95% CI, 1.064-1.136; P < .001). BMI appeared to be the main determinant of serum CRP concentrations in this population. Serum interleukin-6 concentrations were positively associated with the discordant pattern of high CRP and normal ESR values. Conclusion: In this general adult population with no overt inflammatory disease, the discordant pattern of high ESR and normal CRP was associated with greater age, whereas the pattern of high CRP and normal ESR was associated with higher BMI.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Fibroblast Growth Factor 23 and Outcomes in Acute Heart Failure

  • Martí-Martínez, Arancha
  • Nuñez, Julio
  • López-Escribano, Herminio
  • de la Espriella, Rafael
  • Santas, Enrique
  • Rodríguez Borja, Enrique
  • Miró, Òscar
  • Llorens, Pere
  • Alquézar-Arbé, Aitor
  • Herrero-Puente, Pablo
  • Llorens, Pere|||/items/757956aa-c39c-4e15-850b-e5bf9ed72f94
Worsening heart failure (WHF) is a complex clinical syndrome associated with a high risk of mortality and further decompensations, characterized by fluid overload and upregulated inflammatory and fibrotic processes linked to organ dysfunction. Fibroblast growth factor 23 (FGF23) is an emerging proxy of fibrosis and may interact to influence long-term outcomes in WHF patients. This study evaluated the association between FGF23 levels and long-term outcomes in patients with WHF evaluated in the emergency department (ED). A total of 635 patients from the EAHFE registry, enrolled during 2007, 2009, and 2011, were prospectively included. FGF23 was measured in the first blood sample obtained at ED presentation. During a median follow-up of 380 days (interquartile range: 126 to 456), all-cause mortality occurred in 216 patients (34.0%), while 351 patients (55.3%) experienced the composite endpoint of death/WHF ED reconsultation and 295 (46.5%) experienced death/HF hospitalization. Event rates increased progressively across FGF23 levels. Patients with FGF23 above the median (48.4 pg/mL) displayed higher rates (per 100 patient-years) of all-cause mortality (49 vs. 31, p = 0.003), death/WHF ED reconsultation (93 vs. 65, p = 0.003), and death/HF hospitalization (77 vs. 56, p = 0.043). In continuous analyses, each doubling of FGF23 remained significantly associated with an increased risk of all three outcomes after multivariable adjustment. These associations were consistent across clinically relevant subgroups, including those defined by age, sex, and kidney function, supporting the potential prognostic value of FGF23 within this cohort, although external validation is warranted.